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 Dosage compensation in female placental animals is accomplished by 
silencing one of the two X-chromosomes. X-chromosome inactivation (XCI)  is 
initiated early in development by preferentially upregulating the lncRNA Xist 
expression from the future inactive X-chromosome.  The work presented in this 
dissertation aims to understand the transcriptional regulation of Xist during XCI 
induction 
 Xist has long been identified as being both required and sufficient to 
induce X-chromosome inactivation when expressed in cis from the future inactive 
X-chromosome. Xist has 8 exons, is alternatively spliced, 3' polyadenylated, and 
5' capped similar to protein coding genes but is retained in the nucleus.  Multiple 
studies have identified that one of the earliest events of XCI is upregulation of the 
Xist transcript.  However post-transcriptional regulation of Xist hasn't been well 
 ix 
characterized. The role of splicing of lncRNAs is currently unknown. Splicing of 
Xist has possibly been overlooked historically because Xist was first cloned as 
spliced RNA and the spliced form is sufficient to induce XCI therefore most 
studies have focused on the spliced form.  
  In Chapter 2 I show that differentiation induces splicing and that this is 
post-transcriptionally regulated after upregulation of Xist during the initiation of 
XCI. New technologies have allowed identification of a significant amount of 
potential binding partners, suggesting more regulation of Xist exists than was 
previously known.  In Chapter 3, I show a new role for known splice regulator 
PTBP1 in regulating splicing of Xist. My data shows that PTBP1 is required for 
efficient splicing of Xist and suggests that this interaction is indirect and may 
involve additional trans acting factors. In Chapter 4, I show that splicing efficiency 
may be associated with the choice of which X-chromosome to silence during 
induction of XCI.   
 In summary the work presented in this dissertation suggests that splicing 
of Xist is an essential step of Xist induction from the inactive X-chromosome 
during XCI. This work suggests that inefficient splicing of Xist prevents 
expression of Xist, providing potential insight to how ES cells choose which 
chromosome to silence and potential binding partners involved in this choice.  
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Chapter 1: Introduction 
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Introduction to lncRNAs  
Since the structure of DNA was discovered in the 1950s, there has been an 
extensive search to understand the roles and function of our genome.  Upon 
completion of the human genome in 2001, it has since been found that the 
human genome contains over 3 billion base pairs and is estimated to encode for 
~22,000-25,000 protein coding genes, however the actual number in humans is 
currently unknown.  Since the 1970s, much of this noncoding DNA has been 
labeled as "junk DNA" (Ohno, 1972) due to the overwhelming presence of 
transposons, pseudogenes, and simple tandem repeats.  In the 1970s hints 
begun to show that more of the DNA is transcribed than can be solely attributed 
to protein coding genes. With the development of whole genome technologies in 
the 1990s and 2000s, work done by the Encyclopedia of DNA elements 
(ENCODE) project suggests that 75% of the human genome is transcribed into 
processed or primary transcripts (Djebali, 2012).  
 LncRNAs are transcripts that are greater that 200nt, are transcribed by 
RNA Pol II, spliced, 3' polyadenylated, 5' capped, and often lack observable open 
reading frames. Some lncRNAs have cryptic ORFs in their sequence, however 
do not code for proteins.  Some characteristics that have differentiated lncRNAs 
from mRNAs are that on average they are shorter than mRNA transcripts, have 
larger exons, expressed at low levels, are tissue and temporally regulated, 
typically retained in the nucleus, and less conserved among different species 
(Darrien et al., 2012; Cabili et al., 2011). 
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 Originally identified by shotgun sequencing and microarrays, there was an 
ongoing question on the functionality of lncRNAs.  Work by Guttman et al using 
chromatin immunoprecipitation followed by parallel sequencing (ChIP-seq) 
identified about 1,675 intergenic domains marked by H3K4me3 (marks 
promoters) and H3K36me3 (marks exons) domains that didn't overlap with 
current annotated genes.  These transcripts were associated with RNA-binding 
complexes, immune surveillance, ESC pluripotency, neuronal processes, 
morphogenesis, gametogenesis, and muscle development (Guttman et al., 
2009). Many of these lncRNAs promoters showed strong enrichment of RNA Pol 
II binding in ESCs, suggesting they are important for embryonic development.  
 Majority of lncRNAs display tissue specific (TS) expression patterns.  A 
comparative study of 11 tissue types showed that lncRNAs are primarily found in 
a subset of tissue types including the brain, liver, heart, skeletal muscle, and 
retina.  The richest source of lncRNAs however was found in the brain and was 
involved in development, neuronal maintenance, and function (Wu et al., 2013; 
Mattick, 2011). Other lncRNAs are ubiquitously expressed in multiple cell types 
and involved in cellular function and viability.  Ubiquitously expressed lncRNAs 
are shorter than TS lncRNAs, highly expressed, and display more sequence 
conservation (Jiang, Li, and Zhao, 2016).  
 LncRNAs are classified into multiple types 1) intergenic, 2) intronic, 3) 
bidirectional 4) sense and 5) antisense transcripts depending on their location 
relative to protein coding genes.  Intergenic lncRNAs do not overlap protein 
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coding genes while sense and antisense transcripts overlap the sense or 
antisense transcript of a gene respectively. Although much is known about 
expression and location of lncRNAs, the function of these RNA transcripts are 
still being discovered.  
 
Transcriptional regulation of long noncoding RNAs 
LncRNAs have many similarities to mRNAs.  However studies have shown that 
although lncRNAs are lowly expressed they are highly regulated and have very 
specific expression profiles that depend on the cell type, developmental stage, 
tissue type, disease state, and even subcellular compartment they are found in.  
Currently very little is known about the how long noncoding RNAs are transcribed 
however some similarities and differences compared to mRNAs have been 
identified. Overall, lncRNA transcription and post-transcription mechanisms are 
very similar to mRNAs, however they are regulated differentially at their 
biogenesis, maturation, and degradation to account for the observed specificity in 
in lncRNA function and expression.   
 At the level of chromatin, lncRNA transcription initiation is marked by 
increased enrichment of H3K27ac and H3K4me3 marks at the mapped 
transcription start site (TSS) similar to mRNAs.  Presence of H3K4me3 is 
typically sufficient to recruit the RNA Pol II to the TSS, however in lncRNAs 
repression of RNA Pol II binding by chromatin remodelers Swr1, Isw2, Rsc, and 
Ino80 provide an additional step of regulation (Marquardt et al., 2014).   
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 LncRNAs undergo divergent transcription to produce either the sense or 
antisense RNA transcripts.  A well-studied example of divergent transcription is 
the Xist and Tsix sense/antisense pair.  Divergent transcription is enhanced by 
H3K56ac marks and the presence of nucleosome remodelers SWI/SNF and 
CAF-1 involved in nucleosome positioning promoting transcription in coding 
direction (Marquardt et al., 2014). LncRNAs can produce functional transcripts in 
sense/antisense pairs therefore it is important that there are additional regulators 
to assure the correct transcript is being expressed.  This is absent in mRNAs, 
because transcription elongation is only productive in the sense direction. To 
ensure efficient termination of antisense transcripts, polyadenylation sites are 
found to be enriched in the antisense direction and U1 snRNP binding sites are 
enriched in the sense direction to promote efficient splicing (Alamada et al,, 2013 
; Quinn and Chang, H. 2016)  These observations were further supported by 
work done by Krchňákova et al. that shows that strength of 5' splice sites, which 
recognize the U1 snRNP, determines the splicing efficiency of lncRNAs 
(Krchňákova et al., 2018)..   
 In unique cases, some lncRNAs undergo alternative processing different 
from mRNAs.  LncRNAs MALAT1 and NEAT1 undergo 3' cleavage by RNase P 
to produce tRNA like small noncoding RNAs that are transported to the 
cytoplasm to perform their functions.  Some intronic lariats formed by splicing of 
lncRNAs will disbranch and circularize forming ciRNAs.  In some cases the 
introns of lncRNAs will produce sno-lncRNAs which are lncRNAs flanked by two 
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sno-RNAs.  The variance in transcriptional products suggest that lncRNA 
elongation and splicing are involved in their observed specificity in different cell 
types and time points in development. Currently the exact mechanism of splicing 
of lncRNAs is still a mystery and identifying the interacting proteins involved 
would provide insight on how splicing of lncRNAs promotes functional specificity 
in the cell.   
 Regulation of biological processes in the cell often requires direct action of 
the lncRNA itself.  Therefore mechanisms are in place in the cell to degrade 
lncRNAs to ensure proper expression occurs when necessary.  Mutating UPF1 
involved in the nonsense mediated decay pathway (NMD), was shown to 
increase the global expression of lncRNAs in Arabidopsis Thaliana suggesting 
that lncRNAs are targets of NMD.  Poly(A)-binding protein nuclear 1 (PABPN1) 
promotes poly(A) dependent degradation by the nuclear exosome.  PABPN1 
deficiency results in the accumulation of lncRNAs suggesting that lncRNAs are 
also targeted for the nuclear exosome (Quinn and Chang, 2016).  
 Overall lncRNAs are highly regulated by various additional factors to 
ensure that they are expressed in the right place and the right time and degraded 
when their function is completed.  The presence of these fail-safe mechanisms 
further supports the belief that lncRNAs are important in genomic regulation 
during development.  These additional steps serve as stop-points to ensure that 
each step is met at the right time and place in cells and tissues.  
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LncRNAs have diverse roles in genomic regulation  
Only a few lncRNAs have been well characterized to date, however trends in 
their functions are starting to emerge.  Although there is very little sequence 
conservation between species, common modes of action have begun to appear. 
During development lncRNA mediated regulation of transcription has fallen into 
one of four observed categories 1) signals, 2) decoys, 3) scaffolds, and 4) 
guides.  
 LncRNA transcription is responsive to developmental cues and diverse 
stimuli unique to the cellular environment and factors present suggesting 
significant transcriptional control is involved. In this sense, lncRNA transcription 
can serve as molecular signal for a specific cell type or developmental phase.  
LncRNAs Kcnq1 and Air accumulate at promoter region of the paternal X 
chromosome allele in the mouse placenta, signaling silencing in cis of the 
paternal X-chromosome (Mohammed et al., 2009; Wang and Chang 2011).  Xist 
similarly is only expressed from the inactive X-chromosome during imprinted XCI 
and in the epiblast to ensure that random XCI doesn't occur at inappropriate 
times in cells. Another example, lncRNA-ROR expression is positively regulated 
by binding of pluripotency factors Oct4, Sox2, and Nanog. Differentiation 
depletes Oct-4 and lncRNA-ROR to promote differentiation (Loewer et al., 2010). 
 LncRNAs can also regulate transcripts negatively or positively by acting in 
trans as decoys for target proteins and prevent them from binding their gene 
 8 
targets.  Hung et al. found that DNA damage induces the expression of the 
lncRNA PANDA to favor cell cycle arrest (Hung et al., 2011). When expressed, 
PANDA binding to NF-YA is responsible for activating apoptosis (Puvvula et al., 
2014).  
 LncRNAs that possess different binding sites and domains for effector 
molecules can act as scaffolds by recruiting effector proteins to initiate function at 
the correct time and place.  Loss of expression of these lncRNAs would effect the 
proper location of these effector molecules.  For example lncRNA binding of 
PRC1 and PRC2 to the lncRNA ANRIL is required to silence the CDKN2A/B 
locus in cis (Kong et al., 2018). Currently the mechanisms of these interactions 
are not well understood.  
 Guide lncRNAs act both in cis and in trans similarly to scaffolds. Guide 
lncRNAs bind to RNA binding proteins then directs them to their specific target.  
Well-known Xist is an example of a cis acting guide lncRNA responsible for 
directing RNA binding proteins responsible for the associated chromatin 
modifications of the X-chromosome during XCI induction (Lee, 2010; Plath et al., 
2002; Wutz et al., 2002).  
 As technologies become more advanced the ability to identify lncRNAs 
increases.  However much needs to be studied regarding the functions of these 
lncRNAs.  Currently functions have only been assigned to a small subset of 
identified lncRNAs however trends such as their involvement in epigenetic 
regulation of their targets have emerged. Future projects should focus on finding 
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the interacting proteins and regulators of these lncRNAs to gain additional insight 
to their functional roles in the genome.  
X-chromosome Inactivation: How females keep the balance during early 
embryonic development 
Males and females express comparable X-linked gene expression from their X-
chromosomes despite the additional X chromosome found in female eutherian 
animals.  Dosage compensation is accomplished in females through the 
epigenetic silencing of one of the X-chromosomes in females by X-chromosome 
inactivation (XCI). XCI was first postulated in Lyon's 1961 seminal Nature paper 
where she hypothesized that each cell has one active X-chromosome and one 
inactive X-chromosome.  Her hypothesis provided no new data in her 1961 paper 
but was built upon the identification of the bar body in the 1940s by Barr and 
Bertram and Ohno's observation that each cell has one heteropyknotic and 
condensed X-chromosome contrasting to the uncondensed X-chromosome that 
was similar in character as autosomes (Lyon,1961; Ohno, 1959; Barr and 
Bertram 1949). 
 Most studies on XCI have been done in mice that undergo two phases of 
XCI, imprinted and random.  Between the 2 to 8 cell stage in mice, the paternally 
derived X-chromosome is inactivated in each of the cells of the pre-implantation 
embryo.  Cells of the trophoectoderm will maintain the paternal imprint and form 
the extraembryonic tissues such as the placenta. Cells that are fated to become 
the blastocyst will reactivate the paternal X-chromosome resulting in two active 
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X-chromosomes in the blastocyst.  Upon differentiation and cell lineage 
specification, females will compensate for the additional X-chromosome by 
silencing one of the X-chromosomes through random XCI mediated by the 
lncRNA Xist. The progeny of these initial cells of the epiblast maintain this 
silencing throughout cell lineage specification.  All cells in the body will have one 
of the two X-chromosomes silenced.   
 The occurrence of both random and imprinted XCI is unique to mice.  
Marsupials only undergo imprinted XCI of the paternal chromosome.  Other 
eutherians such as rabbits and humans only under go random XCI.  In humans, 
both X-chromosomes remain active until blastocyst formation, however 
expression is dampened on both active X-chromosomes prior to implantation 
(Sahakyan et al., 2017).  X-chromosome dampening (XCD) has only been 
previously observed in C.elegans hermaphrodites (Strome et al., 2014). Currently 
it is unknown if lncRNAs play a role in XCD in either species. 
 Murine embryonic stem cells (ES cells) are derived from the epiblast of the 
post-implantation embryo and house two active X-chromosomes.  Upon 
differentiation, ES cells are able to recapitulate the process of random XCI in 
vitro and serve as useful model for studying XCI.  
 Early studies of XCI have identified the lncRNA Xist as both necessary 
and sufficient for inducing XCI.  When ES cells are induced to differentiate, the 
amounts of X-chromosomes to autosomes are counted and an X-chromosome is 
stochastically chosen to be silenced.  The mechanism of counting and choice of 
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XCI are currently unknown.  The inactive X-chromosome will upregulate 
transcription of the lncRNA Xist from the previously identified X-inactivation 
center (Xic). Following expression, Xist is polyadenylated and spliced, but 
retained in the nucleus.  In the nucleus, the spliced form acts as both a guide and 
decoy lncRNA to bring complexes to the targeted X-chromosome. Xist 
expression is tightly regulated to differentiation status to ensure that XCI isn't 
induced prematurely.  Pluripotency factors Nanog, Oct4, and Sox2 bind to intron 
1 of Xist and repress XCI in undifferentiated cells. Upon differentiation, reduction 
of Nanog, Oct-4, and Sox2 gene expression has been associated with activation 
of Xist expression in cis on the inactive X-chromosome (Navarro et al., 2008).  
 Once activated and transcriptionally processed, stable spliced Xist RNA 
attaches and spreads across the X-chromosome through interactions with CIZ1 
and HnRNPU (Riding-Figueroa et al., 2017; Sunwoo et al., 2017).  Xist coating 
recruits repressive complex PRC1 and 2 and various chromatin modifiers to the 
inactive X-chromosome. These trans acting factors then deposit H2AK119ub and 
H3K27me3 marks to the target X-linked genes preventing their expression.  
 Advancements in deep sequencing techniques have led to the influx of 
identification of RNA binding proteins that bind to Xist (Chu et al., 2015; Mchugh 
et al., 2015).  Currently the functions of these proteins are of growing interest in 
the field but much work still needs to be done.  
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X-chromosome Inactivation and health and disease. 
Random silencing of one of the X-chromosomes in females results in a mosaic of 
X-linked gene expression.  This functional hemizyous characteristic of X-
chromosomes predisposes females to effects of heterozygous mutations in X-
linked genes when XCI is skewed.  If a disease causing mutation is on the X-
chromosome that remains preferentially active, the phenotype can be more 
severe.  On the contrary, if the mutation is on the preferentially inactive X-
chromosome the phenotype can be less severe. In cases where XCI is random, 
the cells that express the wild type gene can lessen or masks the effects of the 
mutant gene.  
 Rett syndrome is a neurodevelopment disorder that exclusively effects 
females and is caused by a mutation in the X-linked MECP2 gene. The severity 
of the disease is tightly associated with the amount of XCI skewing that occurs.  
For example if the active X-chromosome in most of the cells carries the mutated 
version of Mecp2, the disease will be more severe. If the mutated Mecp2 resides 
on the inactive X-chromosome in most cells, the phenotype will be less severe. In 
men, a mutated MECP2 gene results in death shortly after birth because they do 
not have a backup copy of the gene like females (Archer et al., 2007).   
 XCI is protective in X-chromosome aneuploidies.  Extra X-chromosomes 
are largely compensated in males by XCI. Often cells will silence all but one X-
chromosomes in X-chromosome aneuploidies.  Deleterious effects by X-
chromosome aneuploidies are typically caused by changes in expression of 
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"escape" genes.  During XCI, subsets of genes are able to be expressed from 
both the active and inactive X-chromosome and escape XCI. In Klinefelter's 
(XXY) and trisomy X (XXX) males will have an increased expression of these 
escape genes. Male breast cancer has been linked to increases in X-linked gene 
expression in Klinefelter's patients (Rudas et al., 2000).  Turner syndrome 
patients (XO) will have a dosage reduction of these escape genes (Tartaglia et 
al., 2010; Zinn and Ross, 2001).  
 Mutations in escape genes have been associated with cancer.  Mutations 
in escape gene KDM6A have been associated with medulloblastoma, prostate 
cancer, and renal carcinomas (Deng et al., 2014).  Many tumor suppressor and 
oncogenes have been identified as escape genes of XCI.  Cells that carry an 
active oncogene or inactive tumor suppressor can be more prone to cancers 
developing in those tissues.  Therefore differences in escape from XCI and XCI 
skewing can contribute to the phenotypic variances we see in X-linked gene 
based diseases.  
Establishing XCI: Functions of the X-inactivation center, Xist, and 
interacting proteins during XCI induction 
The X inactivation center (Xic) is identified as the minimum locus required for XCI 
and houses various lncRNAs including Xist and Tsix (Brown et al., 1991a; Brown 
et al., 1991b).  Although much has been studied about the function of the Xic, the 
entirety of the full Xic is currently unknown. In eukaryotes, transcription is 
influenced by 3D genomic environment. Techniques such as HI-C incorporates 
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chemical crosslinking with chromatin, fragmentation, DNA ligation and hi-
throughput DNA sequencing to identify neighboring loci genome wide.  Using Hi-
C, Nora et al. observed that the Xic comprises of two topologically associated 
domains (TAD) that are key to spreading of the lncRNA Xist. Genes on the Xic 
are classified as XCI activators and repressors. The respective promoters of Xist 
and Tsix are housed in different TADs. Activators of Xist which promotes XCI are 
housed in one TAD and activators of Tsix that promote repression of Xist and 
XCI are in a separate TAD suggesting the 3D architecture of the Xic is important 
in regulatory function (Nora et al., 2012).  
 Xist has 8 exons and is processed similar to mRNAs but retained in the 
nucleus. It is induced by differentiation and cell lineage specification in the 
epiblast cells of the blastocyst.  Much of the transcriptional regulation of Xist itself 
and how it regulates XCI is currently still being studied. However, current studies 
propose the following model of Xist mediated induction of XCI.  Prior to 
differentiation pluripotency genes Oct4/ Nanog/ Sox2 and CTCF bind to intron 1 
and the regulatory elements of Xist inhibiting its expression.  Upon differentiation, 
depletion of these pluripotency genes promotes expression of Xist (Navarro et 
al., 2008). Upon differentiation depletion of Nanog upregulates expression of the 
E3 ubiquitin ligase Rnf12 which then inhibits expression of REX1, a known 
repressor of Xist expression.  Jpx and Ftx are present 10-100kb distal of the Xic 
(Chureau et al., 2002). Jpx is induced upon differentiation and removes CTCF 
from the promoter of Xist (Tian et al., 2010). Lack of Ftx, represses Xist 
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expression by ~20% but isn't necessary for XCI (Furlan et al., 2018).  The 
combined actions of activators and repressors suggest the need of precise Xist 
expression patterns during induction of XCI. 
 Spliced Xist induces the silencing of X-linked genes through interactions of 
various RNA binding proteins and complexes with the tandem repeat elements 
found in the Xist transcript and the X-chromosome.  Therefore a considerable 
amount of interest in the field has been in identifying the proteins that interact 
with these repeat regions and their effect on XCI. Xist houses 6 known tandem 
repeats A thru F.  Loss of the A-repeat is associated with loss of the Xist 
mediated silencing but doesn't affect Xist localization.  Proteomic and genetic 
screening has identified that the A-repeat binds to chromatin modifiers SPEN, 
RBM15, and WTAP.  Further studies have found SPEN recruits the NCoR-
HDAC3 complex responsible for deacetylating and opening the chromatin on the 
X-chromosome. RBM15 and WTAP are involved in depositing N6-
methyladenosine (m6A) along Xist required for its function (Moindrot et al., 2015).  
Interactions of m6A marks and the m6A binding protein YTHDC1 to mediate Xist 
mediated gene silencing through an unknown mechanism (Patil et al., 2016). 
 Originally it was believed that the A-repeat was involved in recruitment of 
the polycomb repressive complexes 1 and 2 to the X-chromosome, however 
recent studies have observed that to not be the case.  Work done by Pintacuda 
et al. identified that hnRNPK interactions with PRC1 and 2 at the B-repeat are 
responsible for initiating polycomb repressive complex recruitment to Xist 
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involved in Xist splicing. PRC1 and PRC2 catalyzes the H2AK119ub1 and 
H3K27me3 along the X-chromosome respectively (Pintacuda et al., 2017).   
 The E-repeat is found in exon 7 of Xist and has been associated with SET 
histone methyltransferase complex subunit ASH2L however loss of ASH2L 
resulted in upregulation of escape genes without effecting non escape genes. 
Sunwoo et al. found that loss of ASH2L didn't abolish enriched signal of Xist RNA 
on the Xi. Multiple groups have identified CIZ1 anchoring protein as also binding 
to the Xi, however this was shown in somatic cells and differentiated cell types 
(Ridings-Figueroa et al., 2017; Sunwoo et al., 2017). These data suggest that 
ASH2L may be important in regulation of escape genes during the maintenance 
phase of XCI but not necessarily XCI induction. 
 These studies have provided much needed insight on the mechanism of 
Xist mediated XCI and provided a useful approach to understanding lncRNA 
function in gene regulation.  Identification of many RBPs that are direct and 
indirect binding partners of Xist have provided hints on the mechanism of Xist 
mediated silencing however many questions remain.  Currently the function and 
nature of the interaction of these newly identified RBPs and Xist is currently 
unknown.   
Transcriptional Regulation of Xist expression 
LncRNAs are often processed similarly to mRNA transcripts of protein coding 
genes. Many lncRNAs are spliced, 5'capped, and 3' polyadenylated however 
very little is known on how splicing is accomplished. Xist is spliced very similarly 
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to mRNA transcripts however it is never exported out of the nucleus. Studies 
have observed that Xist is primarily unspliced in undifferentiated cells and that 
the spliced version of Xist is sufficient for Xist mediated XCI. However how Xist is 
spliced is unknown.  Xist transcription produces different isoforms depending on 
promoter used, alternative polyadenylation sites, and alternative splicing (Ma et 
al., 2005; Memili et al., 2001; Johnston et al., 1998). Alternative splicing of intron 
7 results in a long and short isoform of Xist. The long isoform is the dominant 
transcript involved in random XCI.  However targeting cells to express primarily 
the short isoform showed no difference is ability to induce XCI (Yue and Ogawa, 
2017).  
Many groups have identified the splicing regulator PTBP1 as binding to the E-
repeat in exon 7 of Xist (Vuong et al., 2016; McHugh et al., 2015; Chu et al., 
2015). PTBP1 is involved in splicing, polyadenylation, and stability of mRNA 
transcripts suggesting a potential role in splicing of the Xist. Interaction between 
the A-repeat and splicing factor ASF/SF2 is necessary for spliced RNA 
accumulation suggesting splicing efficiency of Xist might be one of the factors 
involved in X-chromosome choice to induce XCI (M. Royce-Tolland et al., 2010) 
 
Conclusions 
LncRNAs have varied functions in regulating gene expression.  These studies 
have revealed that lncRNAs overall are important in every step of development.  
Currently the field has gained immense knowledge of how lncRNAs function on 
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their targets, however very little is known on how lncRNAs themselves are 
regulated.  Understanding how lncRNAs are transcriptionally regulated can 
elucidate how they accomplish significant specificity.  The mature Xist transcript 
is involved in XCI however most studies haven't studied how splicing of Xist is 
accomplished.  It is well known that different mRNA transcripts have different 
affinities to their regulatory proteins; therefore it is possible a similar process is 
required for lncRNAs.  Understanding how splicing of lncRNAs is controlled could 
provide insight into how the tissue and temporally specificity of lncRNA function 
arose.    
 To that end, this dissertation will focus on splicing regulation of Xist in ES 
cells. ES cells recapitulate XCI in vitro and will allow us to monitor Xist transcript 
regulation.  In chapter two I will investigate the role of differentiation induced 
splicing and provide insight into its temporal regulation.  In chapter three, we 
explore the effects of known splicing regulator PTBP1 on Xist splicing and XCI.  
One of the ongoing questions of XCI is how the cell knows which X-chromosome 
to silence. In chapter four I will focus on the potential role splicing may have in 
allelic choice of X-chromosome to silence using Mus musculus  129SvJ / Mus 
castaneous (CAS) ES cells known to display skewed X-chromosome inactivation.  
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Abstract 
 
X-inactive specific transcript (Xist) is a long noncoding RNA that is essential to 
the process of X-chromosome inactivation.  Random XCI is mediated by the 
upregulation of female specific Xist from the future inactive X-chromosome (Xi) 
upon differentiation induction.  XCI cannot be induced in the absence of Xist.    
Xist is processed similarly to protein coding gene transcripts, however never 
leaves the nucleus.   Previous studies have primarily used the spliced Xist to 
induce XCI suggesting a potential role of splicing in XCI.  Currently the 
mechanism of splicing of lncRNAs remains a mystery.  We found that Xist RNA is 
primarily unspliced in naÏve ES cells.  Upon differentiation Xist splicing becomes 
efficient across all exons independent of transcription.  Splicing of Xist happens 
post-transcriptionally suggesting one of the checkpoints of XCI induction is 
splicing of Xist once expression of Xist is upregulated to a certain level. These 
findings suggest differentiation induced splicing is one of the checkpoints 
required to induce XCI.  
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Introduction 
 During early development, female placental animals compensate for the 
genetic copy number differences of X-linked genes between males (XY) and 
females (XX), by silencing one of the X-chromosomes in females through the 
process of X-chromosome inactivation (XCI) (Lyon, 1961). In mice this 
chromosome-wide silencing process is a two-phase process, that is cell lineage 
specific, of imprinted and random XCI (Hyunh and Lee, 2003; Okamoto et al., 
2004).  For either random or imprinted XCI to occur, the 17-kb long non-coding 
RNA (lncRNA) X-inactive specific transcript Xist is expressed in cis from the 
targeted X-chromosome (Borsani et al., 1991; Brockdorff et al., 1991; Brown et 
al., 1991).  Accumulation of the Xist on the future inactive X-chromosome has 
been correlated with the initiation of XCI on that same chromosome.  Studies in 
human and mouse has named a unique cis-acting region of the X-chromosome 
name the X-inactivation center (Xic) as the main controller of the expression of 
Xist and induction of XCI (Augui et al., 2011).   
 Immediately upon formation of the zygote, gene expression is bi-allelic 
and expressed from both of the X-chromosomes.  At the two-to-four cell stage, 
Xist is expressed exclusively from the paternal X-chromosome (Xp) (Hyunh and 
Lee, 2003; Okamoto et al., 2004).  Upon expression, Xist coats the Xp in cis from 
the 4-cell stage onward and progressively initiates imprinted XCI (iXCI) 
exclusively on the paternal X-chromosome (Xp) (Maharens et al., 1997; Kay et 
al.,1994).  Upon Xist coating, the paternal X-chromosome is silenced with the 
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removal of methylated H3K4 and acetylated H3K9 activation marks and the 
depositing of repressive H3K27me3 by polycomb complexes (Mager et al., 2003; 
Wang et al., 2001). This imprinted XCI is then maintained in cells fated to 
become the trophoectoderm and the primitive endoderm.  
 Upon implantation of the zygote, X-reactivation of the Xp occurs in cells of 
the inner cell mass of the blastocyst (Mak et al., 2004; Okamoto et al., 2004).  It 
is believed that the initial step of X-chromosome reactivation is the repression of 
Xist on the Xp followed by the loss of these Xp localized repressive complexes. 
Further silencing is accomplished by the loss of repressive histone marks along 
the Xp and reactivation of paternal X-linked genes. The second reactivation 
event, random XCI, occurs upon implantation (Chaumeil et al., 2006; Clemson et 
al., 2006).  After implantation and when epiblast cells begin primordial germ cell 
lineage specification, random XCI takes place.  In epiblast cells both X-
chromosomes are active and the maternal (Xm) or paternal (Xp) X-chromosome 
are stochastically inactivated (Monkhorst et al., 2008).  Once random XCI occurs, 
it is maintained throughout life. 
 Random XCI is initiated by the upregulation of Xist from the future inactive 
X-chromosome (Xi).  In both humans and mice, overwhelming evidence suggests 
that Xist RNA coats the Xi in cis to recruit epigenetic silencing factors involved in 
silencing the X-chromosome (Chaumeil et al., 2002; de Napoles et al., 2004; 
Fang et al., 2004; Plath et al., 2004). The consensus view is that Xist induction is 
necessary for both random and imprinted XCI during development.  
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 X-inactivation occurs during the earliest differentiation steps in embryonic 
development with very little amount of cells available at this stage.  Embryonic 
stem cells, pluripotent stem cells derived from the inner cell mass, are a useful in 
vitro system for studying X-inactivation.  Undifferentiated mouse embryonic stem 
(ES) cells can be maintained in an undifferentiated state and differentiation can 
be induced easily in vitro. Undifferentiated ES cells exhibit two active X-
chromosomes while they are pluripotent.  Mimicking embryonic development, 
females ES cells recapitulate random XCI when stimulated to differentiate (Leahy 
et al., 1999; Monk M, 1981).  
 Xist expression is one of the earliest known events of X-chromosome 
inactivation.  Differentiated ES cells initiate expression of Xist RNA from the 
future Xi chromosome followed by further steps to fully establish XCI (Sun et L., 
2006; Panning et al., 1996). This initiation step involves counting and choice of 
the X-chromosome to be silenced however how this choice is made is currently 
unknown.  Using the embryoid body method, Xist spreads and coats the entire Xi 
in cis as early as 48 hours after induction of differentiation.  After 72 hours, 
continued silencing doesn't require Xist and many characteristics of X-
inactivation have been acquired (Wutz et. al., 2000).  Much later during 
differentiation, chromatin is further modified as XCI becomes fully established 
and irreversible.  Maintenance of XCI after this point appears to be independent 
of Xist RNA expression.  Many studies have suggested various transcriptional 
controls of the initial Xist upregulation (Mak et al., 2004; Okamoto et al., 2004).  
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However, although Xist is processed and spliced, the contribution of post-
transcriptional regulation is still not well characterized. 
 The current model of random XCI is that before XCI initiates, unstable Xist 
RNA is expressed and an unknown blocking factor prevents Xist upregulation 
and its interaction with the Xi in cis.  Upon differentiation, Xist becomes 
upregulated through stabilization, transcriptional upregulation, and/or release of 
this blocking factor (Panning and Jaenisch, 1998).  Stabilized Xist then coats the 
Xi in cis followed by recruitment of chromatin modifications of the Xi (Avner and 
Heard, 2001).  Currently how this choice is made and what initiates this choice is 
unknown.  Additionally, mature Xist is spliced, however the role of splicing of Xist 
if any is currently unknown.  
 After transcription, most lncRNAs are processed very similar to protein-
coding genes.  Most lncRNAs are 5'capped, polyadenylated, and undergo 
splicing, however are not always transported to the cytoplasm.  Why lncRNAs 
are spliced is currently unknown.  Messenger RNA splicing usually allows one 
transcript to make multiple variants and promotes nuclear export to the 
cytoplasm but neither apply to Xist RNA that is retained in the nucleus (Jonkers 
et al., 2008).   
 In UCSC annotation, Xist consists of 8 exons. Retaining and deleting of 
the last intron creates the long and short isoforms respectively.  The long isoform 
is the major isoform and the short isoform is expressed lowly and only in a couple 
differentiated tissues (Ma and Strauss, 2005).  Dominant expression of the short 
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isoform using CRISPR-Cas9 was not distinguishable from the long isoform at 
activating XCI (Yue and Ogawa, 2017).  Therefore it is unclear what role, if any, 
introns have in Xist regulation.  Notably human and mouse Xist is only 47% 
similar but share exon-intron conservation suggesting selection pressure to 
maintain Xist splicing (Hendrich, Brown, and Willard, 1993).  We asked whether 
Xist RNA splicing could be a regulatory checkpoint of Xist biogenesis.  
Surprisingly we found differentiation drastically increased Xist RNA splicing 
efficiency in C57/BL6 ES cells (or BL6 ES cells) or F1 2-1 ES cells ( a hybrid of 
Mus musculus 129SvJaeJ and Mus musculus castaneus EiJ, which has been 
widely used to study allelic expression of Xist and XCI). 
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Results 
ES differentiation induces Xist splicing 
After induction of Xist expression, Xist is 5'- end capped, 3'-polyadenylated, and 
spliced to produce the functional mature Xist transcript.  Barbara Panning's group 
showed that alternative splicing factor 2 / splicing factor 2 (ASF/SF2) binds to the 
A-repeat of Xist and loss of the A-repeat correlated with less processed Xist in 
male ES cells.  It has been shown that XCI fails to initiate on the X-chromosome 
that lacks the A-repeat suggesting that splicing may be a regulatory step for Xist 
induction and function (Royce-Tolland et al., 2010). To investigate the events of 
initial Xist induction, RT-qPCR quality primers were designed to measure total, 
spliced, and unspliced Xist transcripts. For total Xist, primers were designed to 
target within the exon.  By targeting the exon, the primers are not able to 
distinguish between spliced and unspliced transcripts.  For unspliced transcripts, 
the primer pair anneals to a specific splice site hybridizing to the intron and exon 
respectively.  In spliced transcripts these intron primers will fail to bind, allowing 
preferential amplification of only unspliced Xist transcripts.  For the spliced 
transcripts, forward and reverse primers anneal to separate exons separated by 
a large intron.  We used multiple qualified pairs to increase the robustness of the 
analysis.   
 To investigate the initial events of Xist inactivation, we used strand-
specific RT-qPCR to measure the expression of spliced and unspliced transcripts 
after 24 hours of retinoic acid induced differentiation.  Using exon 1 and exon 4 
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targeted primers, I observed that total Xist transcripts were increased after 24 
hours of differentiation of female wild type F1 2-1 ES cell in monolayer culture 
(Figure 1A).  This observation is in agreement with the increase of Xist 
expression upon initiation of XCI.   Using primers targeting various exon junctions 
spanning Xist, I observed a significant and consistent increase in the spliced Xist 
transcript across exon 1 - exon 2, exon 3 - exon 4, and exon 5 - exon 6 (Figure 
1A).  This increase in spliced mature Xist transcripts could be attributed to both 
splicing and RNA decay.  In contrast, I observed a modest but significant 
decrease in unspliced transcripts.  As transcription continues during expression 
of Xist, this modest decrease could be attributed to both continuing transcription 
of new Xist transcripts and splicing of already made transcript (Figure 1A). 
 An increase in spliced Xist could be attributed to the increase of total Xist 
transcripts upon differentiation induction in addition to splicing.  To mask the 
transcription effect and solely look at splicing, I normalized the amount of spliced 
transcripts to the total Xist transcripts before and after differentiation After 
normalization to the total, the increase of spliced Xist was ~2-fold (Figure 1B) 
while the amount of unspliced transcripts was reduced ~3-fold (Figure 1C). 
 Enhanced splicing could explain for the increase in spliced transcript and 
the decreased in unspliced transcript.  To directly test whether splicing is induced 
by differentiation, primers flanking intron 2 (the smallest intron of Xist) to 
simultaneously detect both unspliced and spliced transcripts (Figure 1D). Intron 2 
is only 148nt, so both the unspliced and spliced transcripts can be detected.  The 
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detection of both transcripts allows us to calculate the splicing ratio 
(spliced/unspliced) as a measurement of splicing efficiency.  I found that 
differentiation induced a significant increase in splicing efficiency after 24hrs of 
differentiation in female F1 2-1 ES cells (Figure 1D).  
 To determine if differentiation induced splicing occurs across other introns, 
I focused on intron 1.  Due to the length of intron 1 (2794nt), we were unable to 
find an effective primer flanking the exon 1 - exon 2 of Xist.  Therefore we 
designed forward primers to bind to exon 1 and upstream of the intron 1 - exon 2 
boundary along with a reverse primer to anneal to exon 2.  By multiplex PCR 
using these primers we are able to amplify both the spliced (74nt) and unspliced 
(127nt) Xist transcripts.  I found that in undifferentiated conditions Xist is primarily 
in the unspliced form.  However I observed enhanced splicing consistently after 
24 hours differentiation (Figure 1E). 
 I next wanted to determine if differentiation induced splicing was regulated 
by individual introns or was synchronized across all introns.  Long introns can be 
processed co-transcriptionally and stepwise before exons are joined.(reviewed in 
Georgomanolis, Sofiadis, and Papantonis, 2016). Therefore I wanted to see if 
each flanking exons are spliced concurrently or does splicing occur at different 
rates.  If splicing occurs across different introns at different times, splicing would 
lead to the formation of many isoforms whose introns were not fully removed.  In 
contrast, coordinated splicing would result in either fully unspliced or fully spliced 
transcripts.   It is also possible that some transcripts would have some introns but 
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not all removed.  To determine which of these possibilities was the case for Xist, 
we used primers flanking multiple exons to detect Xist transcripts.   
 My results were consistent to what was seen across individual introns.  In 
both undifferentiated and differentiated conditions, transcripts were either fully 
unspliced or fully spliced suggesting that splicing of introns is synchronized 
(Figure 1F).   Because PCR efficiency is skewed to smaller PCR products in 
long-range PCR reactions, the smaller spliced PCR product (562nt) is over 
represented in our analysis.   
 An increase in spliced transcript could be the result of two possibilities.  
The first possibility is that splicing efficiency increases upon differentiation.   
However another possibility is that once the transcript is spliced, it becomes 
more stable.  If the unspliced transcripts are unstable and have higher rates of 
degradation, that could skew the spliced/unspliced ratio of transcripts in favor the 
spliced population.  To test for the stability of the Xist transcript, I measured the 
half-life of the spliced and unspliced transcript after treatment with 5ug/ml 
actinomycin D.   My data showed that there were no significant differences in the 
stability of both the spliced and unspliced Xist after differentiation (Figure 2A-B). 
This data supports the first possibility that the increase in splicing is due to the 
increased splicing efficiency once differentiation was induced. Our data suggests 
that prior to differentiation, a population of Xist transcript is expressed however 
remains unspliced. 
 
 36 
 
 
 
 37 
 
Figure 1. Differentiation induces Xist splicing (A) RT-qPCR analysis of total, 
spliced, and unspliced Xist transcripts. Adherent F1 2-1 cells were differentiated 
by LIF withdrawal and addition of RA. (B) Ratios of spliced/total Xist transcripts 
quantified by RT-qPCR. (C) Ratios of unspliced/total Xist transcripts quantified by 
RT-qPCR. (D) Splicing assay examines intron 2 splicing before and 24 h after 
differentiation. Representative virtual gel image of intron 2 splicing (left panel). 
Quantified intron 2 splicing ratio (right panel) (E) Splicing assay examines intron 
1 splicing before and 24 h after differentiation. Representative virtual gel image of 
intron 1 splicing (left panel). Quantified intron 1 splicing ratio (right panel). (F) 
Splicing assay examines splicing from exon 2 to exon 6 before and 24 h after 
differentiation. Representative gel image (left panel). PCR cycles were 33 and 29 
for undifferentiated and differentiated cells respectively. For differentiated cells, 
PCR amplification for 33 cycles did not produce the unspliced product and the 
spliced product was over saturated, so amplification of 29 cycles were used for 
the presentation. Quantified splicing ratio (right panel). Error bars indicate S.E.M. 
of three biological replicates. *P-value<0.05; **P-value<0.01; ***P-value<0.001 
Student’s t-test (one-tailed, unpaired). 
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Figure 2. Differentiation has no effect of Xist RNA stability RNA half-lives of 
A) spliced and B) unspliced Xist transcripts before differentiation and 24 hours 
after differentiation. Error bars indicate S.E.M of three biological replicates. ns, p-
value>0.05.  
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 Upon differentiation of the ES cells, Xist continues to be expressed at a 
higher rate on the Xi as splicing of the transcript increases.  Once transcription of 
Xist ramps ups during the early stages of random XCI and splicing of the 
transcript becomes more efficient on the Xi, Xist expression is repressed on the 
active X-chromosome.  It is known that skewing of X-inactivation occurs in 
endogenous conditions; therefore it is possible that splicing efficiency differences 
between different alleles of Xist could be one of the regulatory steps of X 
chromosome inactivation induction.  
Enhanced Splicing is independent of Xist transcription 
As mentioned previously, prior to differentiation Xist is transcribed at low levels 
from both X-chromosomes, however is predominantly unspliced.  Therefore one 
of the unanswered questions regarding Xist is whether these initial transcripts are 
being spliced or if only newly synthesized Xist induced by differentiation are 
being spliced.  This process can be tested by inhibiting transcription of Xist at the 
initial induction of splicing and determining the splicing rates of the transcript.  To 
do this I first needed to identify at what point is splicing initiated after 
differentiation is induced.  Using RT-qPCR I monitored the splicing ratio of Exon 
1- Exon 2 and Exon 2 - Exon 3 each hour post differentiation induction to 
determine when splicing occurs.   My data shows that splicing is low between 1 
and 6 hours post differentiation with retinoic acid and ramps up between 7 and 8 
hours post induction (Figure 3A). After 7 and 8 hrs of induction, splicing steadily 
 40 
increased until 22 hours post induction.  This data suggests that enhancement of 
splicing must occur between 7 and 8 hours of differentiation.   
 To determine if this increase is splicing was processing of already 
transcribed Xist, we inhibited transcription with actinomycin D at 6 hrs post 
differentiation induction with retinoic acid (before splicing enhancement) and 
analyzed splicing at 8 hours and 10 hours of differentiation (Figure 3B). If 
scenario 1 is correct and only newly transcribed Xist is spliced (co-transcription), 
then actinomycin D should prevent the splicing of Xist.  If scenario 2 is correct, 
and already made Xist is spliced, actinomycin D shouldn't have an effect on 
splicing ratios of Xist (post-transcription).  In scenario 2, we should see an 
increase in spliced transcripts after actinomycin D inhibition since already present 
nascent transcripts are still being processed.  
   I found that the amount of spliced transcripts was unaffected by 
actinomycin D, however the amount of unspliced transcripts diminished at 8 
hours and 10 hours when compared to before actinomycin D treatment (Figure 
3C and D).  These data suggests scenario 2 that pre-existing unspliced Xist 
becomes spliced once splicing enhancement occurs at 7 hours post 
differentiation.  
 To quantitatively measure the magnitude of expression changes of 
unspliced and spliced Xist RNA individually, I performed RT-qPCR .   
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Figure 3. Enhanced Xist splicing is independent of Xist transcription 
(A) Representative RT-PCR virtual gel images of intron 1 splicing (top panel) and 
intron 2 splicing (bottom panel) in adherent F1 2-1 cells between 0-22 h post 
differentiation (RA induction and LIF withdrawal). (B) Schematic diagram of 
experimental procedures. Cells were differentiated for 6 hours before treatment 
with 5ug/ml Actinomycin D or control DMSO. RNA was collected before 
differentiation (time 0), at 6 hours post differentiation induction (time 6), at 2, and 
4 hours post treatment (time 8 and time 10). (C) Representative RT-PCR virtual 
gel image of intron 1 splicing following the aforementioned experimental 
procedures. (D) Representative RT-PCR virtual gel image of intron 2 splicing 
following the aforementioned experimental procedures. (E-G) RT-qPCR analysis 
of unspliced Xist transcripts using primers detecting various introns. (H-J) RT-
qPCR of spliced Xist transcripts using primers for various exon-exon junctions. 
Error bars indicate S.E.M of three biological replicates. #, p-value=0.06; *, p-
value<0.05 ; ***, p-value<0.001 Students t-test (1-tailed, unpaired). 
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 Compared to 6 h post differentiation, unspliced Xist stayed relatively flat 
after DMSO treatment, however decreased significantly (~4-fold) after 2h of 
treatment with actinomycin D (Figure 3 E-G).  In contrast, spliced transcripts 
remained upregulated even after transcription inhibition across multiple exons 
(Figure 3H-J). 
 The above results indicate that Xist splicing occurs post-transcriptionally, 
because most previously transcribed unspliced transcripts have completed their 
transcription and have been spliced while there appears to be no change in 
splicing after transcription is inhibited by actinomycin D. Additionally supporting 
post-transcriptional splicing of Xist was data concerning splicing of the upstream 
intron 1 and downstream introns 3, -4, and -5 being consistent with one another 
(Figure 3 E-J). One of the additional steps of post-transcriptional processing is 
polyadenylation of the 3'end.  To further test if splicing is post-transcriptional, I 
looked at the splicing changes of polyadenylated (poly(A)+) RNA fractions. I 
found in undifferentiated cells most of polyadenylated Xist was unspliced, 
however splicing of these poly(A)+ Xist transcripts was enhanced upon 
differentiation (Figure 4A-B). 
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Figure 4. Differentiation induces splicing of poly(A)+ Xist transcripts  (A) 
Intron 1 splicing ratio of polyadenylated Xist transcripts. (B) Intron 2 splicing ratio 
of polyadenylated Xist transcripts. Error bars indicate S.E.M of three biological 
replicates. ***, p-value<0.001 Students t-test (1-tailed, unpaired). 
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Discussion 
 In this chapter we examined the early steps of X-chromosome Inactivation 
by focusing on the lncRNA Xist during differentiation of female ES cells. The goal 
of this chapter was to first identify if differentiation effects splicing of Xist. 
Although it is known that Xist is spliced during XCI, Xist splicing regulation hasn't 
been studied in depth. Differentiation of ES cells mimics the steps of random XCI 
during embryonic development and serves as a model of monitoring Xist 
regulation in vitro. Using strand-specific RT-qPCR we are able to monitor Xist 
total, unpsliced, and spliced transcripts separately and monitor their levels in 
naive and differentiated conditions.  
 Our measurement of the total Xist transcripts using exon specific primers 
in naive WT ES cells showed that in naive conditions Xist is expressed at lower 
levels and is primarily unspliced.  During early stages of differentiation with 
retinoic acid, we see a 2-3 fold increase in total Xist.  Additionally, measurements 
across multiple exons of Xist shows that when normalized to total Xist, spliced 
transcripts are significantly increased in early differentiation and unspliced 
transcripts are significantly decreased.  The observation that the Xist transcript is 
primarily only spliced once differentiation occurs suggest the presence of splicing 
elements that are sensitive to differentiation status.  Downregulation of 
pluripotent factors (i.e. Nanog, Oct 3/4, Sox2)  have been shown as a 
requirement of X-chromosome inactivation initiation (Sousa et al., 2018; 
Minkovsky, 2012; Navarro et al., 2008).  There is a possibility that these 
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pluripotency factors have a role in regulating yet to be identified factors involved 
in the inhibition and activation of splicing. Ciaudo et al. found that loss of mRNA 
degradation regulators Eif1 and Rent1 resulted in inhibition of differentiation 
induced Xist upregulation and inhibition of XCI (Ciaudo et al., 2006).  Upon 
deeper analysis they found that unspliced levels Xist remained similar to WT in 
Eif1 and Rent1 however differentiated induced spliced Xist was reduced further 
suggesting a connection between splicing and XCI. 
 Since the identification of Xist, much has been studied regarding its 
expression, activation, and how it coats the X-chromosome. Although it is known 
that Xist is 5'-capped, 3' polyadenylated, and undergoes alternative splicing, 
splicing is often overlooked. Primarily splicing of protein-coding transcripts is 
necessary for export out of the nucleus, however Xist is retained in the nucleus.  
Splicing of lncRNA Blustr is required for activation of neighboring gene Sfmtb2 
(Engreitz et. al.). Possible reasons very few studies on splicing are done is 
because i) Xist was identified as spliced cDNA ii) spliced Xist is sufficient to 
induce XCI iii) methods for Xist detection have been designed to detect spliced 
Xist and iv) Xist splicing thought to occur rapidly and passively.  
 PCR efficiency is skewed to smaller amplicons due to ease of 
amplification, therefore when measuring spliced and unspliced transcripts, 
consideration should be taken to ensure that the amplicons are close in size.  In 
cases of large differences in amplicon sizes, there is an underlying bias to 
amplify the smaller amplicon.  To measure splicing accurately we examined 
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intron 2 which yielded amplicon sizes 239 and 90 bp.  (Figure 1D).  For analyzing 
intron 1, I used multiplex PCR to amplify similarly sized amplicon (unspliced 
127bp vs spliced 74bp (Figure 1E). The splicing across intron 2- intron 5 (exon 2 
- exon 6 , Figure 1F) demonstrates this bias.   When comparing the splice ratios 
after differentiation, we see an increase across exons, however the increase is 
significantly higher across exon 2 to exon 6, possibly due to bias of amplifying 
the 562nt spliced amplicon as compared to the much larger 1930nt unspliced 
amplicon. 
 Splicing can occur individually per intron or coordinated across all of our 
introns.  In the scenario that splicing occurs individually there could possibly be 
isoforms that aren't fully spliced.  Our data shows that Xist is either completely 
spliced or unspliced.  When looking across various exon regions, only a 
completely spliced or the completely unspliced isoform is amplified.  This 
suggests that splicing occurs coordinately across exons.  
 In our data we observed that the unspliced fraction of Xist decreased after 
differentiation.  This could be due to two possibilities: i) unspliced transcripts are 
more easily degraded or ii) differentiation induces splicing of the present 
transcripts. Consistent with scenario 1, stability of spliced transcripts on the Xi 
and instability on the Xa has been suggested as one of the essential steps of Xist 
continued expression and induction of XCI. (Panning, Dausman, Jaenisch, 
1997).  In ES cells treated with actinomycin D, we saw no differences in stability 
between unspliced and spliced before and after differentiation transcripts (Figure 
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2A-B). Supporting scenario 2, our data suggests that differentiation induced 
splicing of present and new transcripts results in the increase in splicing ratio.  
 Prior to differentiation Xist is expressed at low levels from both active X-
chromosomes in the inner cell mass of the epiblast.  Splicing can occur 
concurrently with transcription (co-transcription) of after transcription has been 
completed (post-transcription).   One question in the field is whether 
differentiation induces splicing of Xist or only newly transcribed Xist is spliced. 
Inhibition of Eif1 and Rent1 only reduced spliced Xist in differentiated cells while 
unspliced Xist levels remained the same as WT (Ciaudo et al., 2006).  Cells with 
reduced levels of differentiation induced spliced Xist could not activate XCI. 
Inhibition of transcription with actinomycin D resulted in no change in splicing 
efficiency in WT ES cells.  In the same ES cells unspliced transcripts were 
significantly decreased compared to DMSO treated controls.  Our data suggests 
that splicing occurs post-transcriptionally when most Xist has completed 
transcription. This is further supported by our data that found spliced 
polyadenylated (poly(A)+) transcripts were enhanced in differentiated conditions.  
 Although Xist splicing has not been studied extensively, the role of splicing 
has been suggested in other publications.  Studies using a doxycycline inducible 
transgene expressing exclusively spliced Xist were sufficient to induce XCI in 
undifferentiated ES cells as long as induction was done in the first 48 hours 
(Wutz and Jaenisch, 2000). Other studies done by Royce-Tolland et al. have 
shown that loss of the A-repeat prevents activation of XCI in the mutated X-
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chromosome   The A-repeat in exon 1 of Xist binds to alternative splicing factor 2 
/ splicing factor 2 (ASF2/SF2) (Royce-Tolland et al., 2010).  Loss of the A-repeat 
results in a significant decrease in spliced transcripts in the mutated X-
chromosome, however levels of unspliced Xist are comparable to WT. They also 
showed that RNA interference inhibition of ASF2/SF2 was sufficient to inhibit 
splicing of Xist. In both of these studies only changes in the splicing efficiency of 
Xist resulted in inhibition of XCI, further supporting Xist splicing as a regulatory 
step in XCI during the earliest steps of differentiation.  
 Taken together our results in WT cells suggest that in undifferentiated 
cells, Xist is expressed at low levels and remains unspliced. Once differentiation 
is induced, Xist expression ramps up initially however splicing at this point is still 
low.  As Xist expression increases it begins to recruit splicing factors to the 
transcript. Once Xist is at a critical concentration at around 7-8h post induction 
(Figure 3A) and enough splicing factors are recruited to the transcript, splicing 
ramps up.  As Xist is spliced it begins to recruit various binding factors to initiate 
silencing.  The absence of splicing changes in undifferentiated cells suggests 
both differentiation and splicing of Xist are some of the earliest steps in XCI 
induction.    
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Table 1.1 Xist Splicing Primer Sequences 
Region species Forward Primer Reverse 
Primer 
Size 
(unspliced) 
Size 
(Spliced) 
Xist 
E2_E3 mouse 
TGCTGGAGAGA
GCCCAAA 
 
TTCTGCTGAG
ATGTAATGTA
GCTGT 
239 90 
Xist 
E1_E2 mouse 
CTACTGCTCCT
CCGTTACATCA 
AGGAGCACA
AAACAGACTC
CA 
2868 74 
Xist  
I1-E2 mouse 
ACCAATTGAAA
ACGCTGACA 
AGGAGCACA
AAACAGACTC
CA 
127   
Xist 
E2_E6 mouse 
TGCTGGAGAGA
GCCCAAA 
AAGACCCAG
TTTTCTGTGC
TG 
1930 562 
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Materials and Methods 
Cell culture  
Feeder independent WT female F1 2-1 mouse ES cells were expanded on 0.1% 
gelatinized tissue culture plates in 2i culture media containing 50% Neurobasal 
(Gibco cat. no. 21103049) and 50% DMEM/F12 (Gibco cat. no. 11320082) 
supplemented with 1% B27+RA (Gibco cat. no. 17504044), 1% N2 Supplement 
(R&D System cat.no. AR009), 1% Glutamax, 7.4 mM B27 Fraction V (Gibco cat. 
no. 15260037), 1% Penicillin-Streptomycin (GE Healthcare Life Sciences cat. no. 
SV30010), 3 µM CHIR99021 (Sigma cat.no. SML1046), 1 µM PD0325901 
(Selleckchem cat. no. S1036), 150 µM 1-thioglycerol (Sigma cat. no. M6145), 
and 1000 U/ml mLIF (Gemini Bio-Products cat. no. 400-495). To assist in initial 
attachment, 2i medium was supplemented with 2% ESC grade FBS for the first 
24 hours then switched to serum free. To prevent emerging of colonies and 
spontaneous differentiation, cells were passaged every two days.  
Differentiation of embryonic stem cells 
For monolayer differentiation, cells were plated at 200-300 x 103 per 6-well and 
were grown in LIF conditions for 24hrs and then LIF was removed and cells were 
grown in differentiation media for 24 hours (DMEM supplemented with 15% ESC 
FBS, 1% Nucleosides, 1% L-glutamine, 0.1mM beta mercaptoethanol, and 1 µM 
retinoic acid (Sigma cat. no. R2625)). RNA was collected at 24 hours post 
retinoic acid addition. To minimize cell death, media was replenished every 2 
days.  
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Actinomycin D Treatments 
Cells were plated at 100 x 103 per 6-well for 24 hours (h) prior to actinomycin D 
treatment.. For transcription inhibition prior to the inflection point of enhanced 
splicing, cells were differentiated for 6 h in media lacking leukemia inhibitory 
factor (LIF) and supplemented with 1µM retinoic acid.  After 6 h of differentiation, 
cells were treated with 5 µg/ml actinomycin D for 4 h added directly to growth 
media. Total RNA was collected from undifferentiated cells (0h), after 6 h of 
differentiation, and after 2 h or 4 h of actinomycin D post treatment (8h and 10h).  
RNA Isolation, cDNA synthesis, and RT-qPCR 
Trizol isolation of RNA was performed following manufacturer's protocol (Life 
Technologies). Isolated RNA was treated with 4 units of Turbo DNase (Ambion) 
at 37 °C for 35 minutes to degrade any remaining DNA. RNA was purified using 
Phenol-Chloroform (pH 4.5, VWR cat. no. 97064-744). RNA concentrations were 
measured using Nanodrop 2000c (Thermo Fisher). First-strand cDNA was 
generated using 1 µg RNA and 200 units of M-MLV reverse transcriptase 
(Promega cat. no. M1705) with a RT primer in a 20 µl reaction following the 
manufacturer's protocol. For Xist specific analysis, the RT primer was a Xist gene 
specific reverse primer (E6-E7 reverse) targeting exon 7 (50µM). For X-linked 
and differentiation genes random hexamers (30µM) were used. For 
polyadenylated (poly(A)+) RNA, oligodT primers (50µM) were used for cDNA 
generation. The RT-qPCRs were conducted using a Quantstudio 6 Flex Real-
Time PCR instrument, 2x Syber Master Mix (Life Technologies) following 
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manufacturer's protocol. Three technical replicates of all samples were 
performed for each biological replicate. An additional no-template control was 
included in every experiment. Outliers were defined by a Ct variance higher than 
0.5. Analysis was done with Quanstudio 6 software and Microsoft Excel. 
Statistics test were based on ∆∆Ct values. 
Splicing assay 
RT-PCRs were performed under standard conditions for Taq polymerase from 
New England Biolabs (cat. no. M0267E). For amplification of spliced regions of 
Xist spanning exons 1-2, exons 2-3, and exons 2-6, exon specific primers for 
corresponding exons were used Table 1. The PCRs were performed at a Tm of 
60C for 29-35 cycles. PCR products greater than 1kb were resolved in 1.5% TAE 
Agarose gel. Smaller products were resolved with capillary electrophoresis 
(QIAxcel Advanced System) or on a 2% TBE Agarose gel. Relative quantities of 
spliced and unspliced products were measured on the QIAxcel software (Qiagen) 
or ImageLab (Bio-Rad) and the splicing ratio was calculated as the molar ratio of 
spliced to unspliced PCR products. The electropherograms of capillary 
electrophoresis were converted to virtual gel images by QIAxcel for presentation.  
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Chapter 3: Regulation of Xist splicing by RNA binding protein 
Polypyrimidine Tract Binding Protein 1 
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Abstract 
LncRNAs are being recognized as important in the regulation of developmental 
processes.  Many lncRNAs are processed similar to protein coding genes in 
order to perform their function, however the precise mechanism of splicing of 
lncRNAs is still unknown.  Recent studies have identified many potential RNA 
binding partners of Xist, however the nature and importance of these interactions 
are currently being studied. Our group and others found that polypyrimidine tract 
binding protein 1 (PTBP1) binds to exon 7 of Xist.RNA. PTBP1 is a known 
splicing regulator of protein coding genes and is expressed early in development. 
We found that in female ES cells that lacked PTBP1 fail to significantly 
upregulated mature Xist because a defect in Xist splicing. Our data suggests that 
PTBP1 is important in regulating splicing of Xist at the onset of Xist dependent 
XCI and that this interaction is indirect and may involve other transacting factors.   
 
  
 
 
.  
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Introduction 
New technologies have allowed for unprecedented identification of new genes. 
Full genome sequencing surprisingly has led to the discovery of many long 
noncoding RNAs but not many new protein genes. Although their functions are 
still being discovered, studies in cell lines and mouse models demonstrated 
lncRNAs as regulators of gene expression and silencing (reviewed by Rinn and 
Chang, 2012).  LncRNAs are shown to regulate transcription of related genes by 
i) acting as decoys to prevent proteins from access to the DNA ii) as a scaffold to 
bring multiple proteins together to form complexes or iii) guides that target gene 
regulation in allele specific fashion (Spitale, Tsai, and Chang, 2011; Kino et 
al.,2010;  Rinn et al, 2007).   
 Xist is an example of a scaffolding lncRNA.  After differentiation, Xist 
expression is upregulated and then is spliced. Spliced Xist then acts as a 
molecular scaffold for multiple protein factors and protein complexes (Smola et 
al., 2016; Chu et al., 2015; McHugh et al., 2015). RNA binding proteins identified 
have been associated with global structure of Xist and temporally regulated by 
cell-induced changes.  However, the nature of these protein-RNA interactions are 
debated and not fully understood in the field.  The accepted belief is that Xist 
function primarily depends on the primary Xist transcript (Borsani et al., 1991; 
Brockdorff et al., 1991; Brown et al., 1991).  Xist is processed similarly to protein 
coding genes, however the steps and factors involved haven't been studied in 
depth.  However studies into the structure and the nature of these protein RNA-
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interactions with Xist suggest both the primary sequence and the structure are 
important for silencing the X-chromosome (Smola et al., 2016; Lu et al., 2016; 
Chen et al., 2016; Fang et al., 2015). 
 Xist undergoes splicing and polyadenylation, however the general role of 
intron splicing of Xist is unknown.  In protein coding genes, processing of mRNA 
is required for nuclear export to the cytoplasm while alternative splicing allows for 
multiple functional variants from an individual primary transcript. Neither applied 
to Xist, which is retained in the nucleus and only has two known isoforms that 
differ on the 3' end.  Xist has 8 exons and retention or splicing of intron 7 
determines the expression of the long or short isoform of Xist (Ma and Strauss, 
2005).  The long isoform is the primary isoform expressed in ES cells during 
differentiation and involved in XCI, however the short isoform is expressed in 
other tissues. Work by Yue et al. has shown that the short or long isoform of Xist 
are indistinguishable in their activation of Xist (Yue and Ogawa, 2017). Therefore 
the question remains of what is the role of intron splicing is in Xist. 
 Interestingly, human and mouse Xist have 47% similarity, however their 
exon-intron structure and key repeat regions are conserved suggesting functional 
importance (Nesterova et al., 2001). In recent years many RNA binding proteins 
have been identified as binding to key repeat regions of Xist (Smola et al., 2016; 
Chu et al., 2015; Minajigi et al., 2015; Mchugh et al., 2015).  Identified RBPs that 
interact with Xist are temporally regulated, involved in the 3-D chromatin 
structure, gene silencing on the X-chromosome, and in the attachment of Xist 
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RNA to the X-chromosome during XCI, however the function of many identified 
RBPs in XCI regulation is still unknown (reviewed by da Rocha and Heard, 
2017). Different subsets of RBPs have been shown to associate with Xist in 
undifferentiated and differentiated conditions, suggesting that RBPs may 
functionally regulate Xist during induction of XCI.  
 Xist is involved in multiple steps of X-chromosome inactivation mediated 
by protein interactions with key repeat regions in the Xist primary sequence.  
There are 7 identified repeat regions A thru F in Xist .  The A-repeat is the most 
conserved and is essential for XCI mediated transcriptional repression.  XCI fails 
to be induced by Xist lacking the A-repeat. Repeats BCD are associated with 
PRC1/2 in depositing histone methylation marks during XCI.  Multiple groups 
have identified PTBP1 as binding to the E-repeat of Xist (Vuong et al, 2016; Chu 
et al., 2015; McHugh et al., 2015)   
 The E-repeat is in exon 7 of Xist, is highly conserved in eutherian 
mammals, and is required for stable localization of Xist on the XCI .  The E-
repeat is associated with recruitment of AS2HL chromatin modifying enzyme in 
regulating histone modifiers and escape gene expression, however it's 
importance in Xist regulation is currently unknown (Yue et al., 2017).  PTBP1 is a 
known regulator of the export, splicing, stability, and export of mRNAs of protein 
coding genes.  PTBP1 is temporally regulated and is involved in regulation of 
genes during differentiation.   PTBP1 has also been identified in a forward 
genetic screen as impairing XCI.  Considering PTBP1 is known to regulate 
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splicing and stability of precursor transcripts, in this chapter I tested whether 
PTBP1 is a regulator of differentiation induced splicing of Xist.  
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Results 
Our lab and other labs have discovered that PTBP1 binds to Xist in the E-repeat 
of exon 7 (Vuong et al., 2016; Chu et al., 2015; McHugh et al., 2015). To test 
whether PTBP1 influences exon splicing, our lab generated female Ptbp1-/- ES 
cells from a Ptbp1loxp allele via homologous recombination.  The Ptbp1loxp allele 
contains two loxp sites flanking exon 2 of Ptbp1 (Figure 5A).  Deletion of exon 2 
in Ptbp1 eliminates functional PTBP1 proteins (Boutz et al., 2007; Makeyev et al., 
2007; Spellman et al. 2007). The female Ptbp1-/- ES cell line was validated by 
genotyping PCR (Figure 5B) and confirmed with western blot using an antibody 
that recognizes the N terminus of PTBP1 (Figure 5C). In another PTB, PTBP3, 
the deletion of the equivalent exon to exon 2 results in a N-terminally truncated 
protein isoforms. To test whether deletion of exon 2 resulted in N-terminally 
truncated PTBP1, we used an antibody reactive to the C-terminus of PTBP1. We 
observed a smaller and less abundant protein (Figure. 5D), which might 
correspond to a N-terminally truncated PTBP1.  To test loss of PTBP1 function 
we looked at splicing of Ptbp2. PTBP1 represses exon 10 inclusion in Ptbp2 thus 
targeting Ptbp2 for nonsense mediated decay.  In Ptbp1-/- ES cells we observed 
only Ptbp2 transcripts with exon 10 retained (Figure 5E-F).  
Xist RNA splicing is impaired in Ptbp1 mutant cells 
 PTB proteins house both a nuclear localization signal (NLS) and nuclear 
export signal (NES) and shuffle between the cytoplasm and the nucleus (Garcia-
Blanco, Jamison, and Sharp,1989 ; Ramanelli et al 1997; Li and Yen, 2002).  
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Figure 5. Characterization of Ptbp1 mutant ES cells A) Schematic of 
Ptbp1 gene structure in Ptbp1loxp/loxp and Ptbp1-/- (or Ptbp∆E2/∆E2)cells, and 
the genotyping primers used. Close triangles represent loxp sites. 
Ptbp1loxp/loxp and Ptbp1-/- are herein referred to as WT and KO, 
respectively. (B) Representative gel shows genotyping of WT and Ptbp1-/- 
ES cells using different genotyping primer pairs. (C) Western blot 
confirmation of PTBP1 knockout using an anti-PTBP1-NT antibody. (D) 
Western blot of Ptbp1-/- ES cells versus WT control using PTBP1 C-
terminus antibody. Left: overlapping blots of PTBP1 (in green) and 
GAPDH (in red). Right: over-exposed PTBP1 Western (high PMT) shows 
a smaller and substantially less abundant protein (arrow) in the Ptbp1-/- 
ES cell sample. (E) Western blot showing increase in PTBP2 expression 
in Ptbp1-/- ES cells. (F) Representative virtual gel image showing 
increased Ptbp2 exon 10 splicing in Ptbp1-/- ES cells versus WT control. 
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Studies from other groups have show that PTB proteins are involved in splicing, 
polyadenylation, mRNA stability, and translation initiation.  
 How PTB proteins function depends on their localization and interactions 
with other binding factors. (Perez et al., 1997; Kamath et al., 2001; Li and Yen, 
2002).  I wanted to determine if PTBP1 had any functional roles in splicing of 
Xist. Cells become insensitive to Xist inactivation as early as 48 hrs post 
differentiation (Wutz and Jaenisch, 2000). WT BL6 showed a significant increase 
in spliced exon 1 - exon 2 and exon 2-exon 3 when differentiated in monolayer 
growth conditions for 24 hours (Figure 6A-B).  Ptbp1-/- cells displayed lower 
splicing when compared to WT cells (Figure 6A-B).  Ptbp1 regulation can be 
exon specific so next I wanted to test if the splicing defect was only present in 
individual exon splicing events or across all exons.  To distinguish these 
possibilities, I used primers flanking multiple exons (2-6 and 3-7). Our results 
show that loss of Ptbp1 resulted in less splicing across multiple exons when 
compared to WT BL6 ES cells (Figure 6C-D).  
 PTBP1 has cellular functions in stability of RNAs as well as splicing.  
Studies show PTBP1 expressed at the earliest in the epiblast cells (Suckale et 
al., 2011).  An alternative explanation for the decrease of spliced Xist transcripts 
in Ptbp1-/- cells is a decrease of the spliced transcript in female Ptbp1-/- ES 
cells.  In this scenario, even if splicing can proceed, loss of spliced transcripts 
would attenuate and differentiation enhanced splicing ratio in Ptbp1-/- ES Cells.  
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Figure 6. Xist RNA splicing is impaired in monolayer Ptbp1 mutant ES cells 
Representative virtual gel image (left panel) and quantified splicing ratio (right 
panel) for (A) intron 1, (B) intron 2 , (C) intron 2 thru intron 5, and (D) inron 3 to 
intron 6 in WT and Ptbp1-/- cells upon differentiation using the 24 hour 
monolayer method. Error bars indicate S.E.M of three biological replicates. #, p-
value=0.06; *, p-value<0.05 ; ***, p-value<0.001 Students t-test (1-tailed, 
unpaired). 
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Figure 7. Xist RNA stability is not impaired in monolayer Ptbp1 mutant ES 
cells (A-C) The half-lives of spliced Xist RNA do not change before or 24 hours 
after differentiation. Percent remaining spliced Xist transcripts after actinomycin-
D treatment are measured using primer pairs targeting A) Exon 1 to Exon 2 and 
(B) Exon 6 to Exon 7. Error bars indicate S.E.M of three biological replicates. ns; 
Students t-test (1-tailed, unpaired). 
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However I observed no change in stability of WT Bl6 and Ptbp1 -/- ES cells 
treated with actinomycin D before or after differentiation (Figure 7A-C). 
 PTBP1 and PTBP2 have similar functions with PTBP2 expression 
upregulated later during differentiation when PTBP1 levels go down.  Xist 
mediated X-inactivation is irreversible as early as 48 hours. Embryoid body (EB) 
differentiation of ES cells in suspension culture is the favored model to mimic 
later phases of differentiation.  I next asked if Ptbp1-/- defects in splicing were 
maintained at later stages of differentiation. EB differentiation for 2 to 4 days in 
WT Bl6 ES cells dramatically enhanced Xist splicing, however Ptbp1-/-  cells 
displayed lower splicing ratios than WT cells( Figure 8A-B). 
 Since loss of PTBP1 showed a splicing defect in Ptbp1-/- ES cells and 
enhanced splicing in WT ES cells, I wanted to determine if Xist splicing levels 
correlated with PTBP1 protein levels during EB differentiation.  I observed an 
increase in PTBP1 in undifferentiated and 24 hours after differentiated, however 
PTBP1 levels steadily decreased from day 2 through day 8 (Figure 9A-B).  Xist 
splicing efficiency is therefore not correlative with PTBP1 protein expression. 
PTBP1 protein is high in undifferentiated cells, which is supported by work in 
other groups that showed PTBP1 is expressed in the epiblast.  
 One of the early activators of Xist induction is induced by downregulation 
of pluripotency factors during differentiation of ES cells. One possibility for this 
observed reduction of Xist transcripts, was that Ptbp1-/-  ES cells differentiated 
more slowly than WT cells.   
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Figure 8. Xist RNA splicing is impaired in Ptbp1 mutant embryoid bodies 
Representative virtual gel image (left panel) and quantified splicing ratio (right 
panel) for (A) intron 1, (B) intron 2 in WT and Ptbp1-/- embryoid bodies, Error 
bars indicate S.E.M of three biological replicates. #, p-value=0.06; *, p-
value<0.05 ; ***, p-value<0.001 Students t-test (1-tailed, unpaired). 
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Figure 9. Expression of PTBP1 in wildtype embryoid bodies (A)Western blot 
analysis of PTBP1 levels during embryoid body differentiation in WT cells. (B) 
Quantification of PTBP1 normalized to GAPDH. 
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To test this I measured the expression of pluoripotency marker Nanog, epiblast 
marker Fgf, and neuroectoderm marker Zfp521 (Figure 10A).  In WT ES cells our 
data showed that Nanog expression decreased at day 2 and then slightly 
reactivated at day 4 as previously noted by Trott et al. (Trott et al., 2013).  
Increases in Fgf5 are seen as early as day 2 and Zfp521 at day 4, consistent with 
sequential steps of cell lineage specification. Ptbp1-/- ES cells showed similar 
levels of Nanog , Fgf5, and Zfp521 in undifferentiated cells (day 0).  
Differentiated Ptbp1-/- EBs displayed decreased levels of Nanog, and increased 
levels of Fgf5 and Zfp521 compared to WT suggesting earlier exit from 
differentiation (Figure 10A-C).  Differentiation enhances XCI induction, if PTBP1 
regulated Xist splicing through its effect on differentiation, we should of observed 
higher levels of splicing in Ptbp1-/- cells.  Our data suggests that PTBP1 
regulation of Xist splicing is permissive and not instructive.  PTBP1 levels do not 
appear to instruct Xist splicing levels, however PTPB1 needs to be present at an 
initial certain level to enhance Xist expression and for splicing to ramp up.  
Additionally, I observed no morphological defects in Ptbp1-/-  ES cells during 
differentiation (Figure 10D).  PTPB1 effects on Xist splicing appear to be 
independent of its effect on cellular differentiation (Figure10E) 
 Proper induction and maintenance of random XCI is responsible for 
silencing of X-linked genes.  Ptbp1-/- ES cells display significantly impairs 
splicing of Xist as early as 24-48 hours post differentiation prior to when XCI 
becomes irreversible.  Therefore I asked whether Ptbp1-/- resulted in de-
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repression of X-linked gene targets of XCI.  I observed that Ptbp1-/- cells showed 
modest increases in X-linked genes Glucose-6-phosphate 1-dehydrogenase 
(G6pdx) and Lysosome-associated membrane protein 2 (Lamp2), however 
showed a modest decrease in Phosphoglycerate Kinase 1 (Pgk1) (Figure 10F-
H).  One possibility is that low levels of spliced Xist present in absence of Ptbp1 
could accumulate over time and can induce some levels of XCI. However the 
assays used are probably not sensitive enough to detect XCI.  Another possibility 
is that there are other factors independent of Xist involved in X-linked gene re-
activation as shown by Yang et al (Yang et al., 2016). 
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Figure 10. The effects of mutant Ptbp1 on differentiation and XCI target X-
linked genes (A-C) RT-qPCR analyzes expression levels of (A) pluripotency 
gene Nanog, (B) epiblast marker Fgf5, and (C) neuroectoderm marker Zfp521 in 
WT and Ptbp1-/- embryoid bodies normalized to respective undifferentiated 
controls (day 0). (D) Embryoid body formation in undifferentiated WT and Ptbp1-
/- ES cells (day 0) and at day 2 and 4 during differentiation. (E) A schematic 
summarizing the relationship between differentiation (F-H) RT-qPCR analyzes 
expression levels of X-linked genes (F) G6pdx, (G) Lamp2,  and (H) Pgk1.  WT 
and Ptbp1-/- embryoid bodies normalized to respective undifferentiated controls 
(day 0). *, p-value<0.05 ; **, p-value<0.01; ***, p-value<0.001 Students t-test (1-
tailed, unpaired). 
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Discussion 
In this chapter I examined the role of polypyrimidine tract binding protein 1 
(PTBP1) had in regulating the lncRNA Xist .  For many years, groups have 
studied the factors involved in Xist regulation and transcriptional silencing of the 
X-chromosome. Studies so far focused the genes involved in regulating the 
activation of Xist upon initiation of differentiation and cell lineage specification.  
Recently, studies have focused on identifying what binding partners are involved 
in Xist mediated silencing of the X-chromosome during XCI induction.  RNA 
binding proteins have long been shown to be involved in the fate of all transcripts 
including lncRNAs in the cell.  
 Multiple groups recently identified many RBPs that interact with Xist are 
involved in RNA modeling pathways, chromatin modifications, splicing, and the 
nuclear matrix. One RBP, PTBP1 was shown by multiple groups as binding to 
the E-repeat in exon 7 of Xist (Vuong et al., 2016; Chu et al., 2015; McHugh et 
al., 2015).  PTBP1 is a known regulator of splicing, polyadenylation, and 
transport of mRNAs.  By focusing on PTBP1, we found that loss of PTBP1 in 
Ptbp1-/- ES cells resulted in earlier exit from pluripotency and significantly 
impaired (but not completely inhibit) splicing of Xist.  Our data suggests a model 
in which PTBP1 serves a permissive role in Xist splicing rather than instructive 
and that this role may be indirect in differentiated ES cells.  
 In the previous chapter we showed that differentiation induces splicing of 
Xist. ES cells lacking Rent1 or Eif1 only reduced differentiation induced spliced 
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Xist, however unspliced transcripts levels remain the same as WT. The cells are 
also unable to upregulate Xist and fail to induce XCI suggesting a connection 
between splicing and XCI activation (Ciaudo et al.,2006). Therefore we set out to 
identify if PTBP1 is an early regulator of Xist splicing upon differentiation 
induction.   
 We observed significantly impaired splicing of Xist in differentiated  
Ptbp1-/- ES cells in both monolayer and embryoid body models compared to WT 
Bl6 cells.  In both WT and Ptbp1-/- ES cells we see primarily unspliced 
transcripts in undifferentiated cells.  In WT BL6 ES cells, Xist is spliced after 1 
day of differentiation and maintained at similar levels of spliced transcripts during 
extended differentiation.  However, Ptpb1-/- ES cells display significant 
impairment of splicing as early as 1 day remains impaired throughout 
differentiation. There were no observed differences in stability of WT Bl6 and 
Ptpb1-/- ES cells suggesting PTBP1's regulation of Xist is based on changes in 
splicing efficiency. This data was intriguing since it suggests that splicing is 
regulated very early in differentiation and then maintained, and this initial splicing 
regulation is regulated in part by PTBP1. Our data was consistent with studies by 
Wutz et al. that suggested that the initiation window of when Xist can initiate 
repression is limited to the 32 hours post differentiation before X-inactivation 
becomes irreversible at 72 hours post differentiation (Wutz and Jaenisch, 2000). 
 PTBP1 is expressed in undifferentiated ES cells at 24 hours of 
differentiation but starts to decrease at 48 hours.  We observed splicing 
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impairment in Ptbp1-/- ES cells is beyond 48 hours. This data suggests that 
some level of PTBP1 is required at initiation of differentiation to induce splicing of 
Xist, but splicing isn't correlated to the amount of PTBP1 present.  This suggests 
that PTBP1 is more permissive instead of instructive in Xist splicing at the 
initiation of differentiation. This is consistent with work done by Chu et al. that 
found different proteins interact with Xist in a developmentally related manner in 
undifferentiated and differentiated cells (Chu et al., 2015).  
 Xist induction is tightly correlated with pluripotency status. Exit from 
pluripotency is associated with higher levels of Xist and induction of random XCI.  
However in Ptbp1-/- embryoid bodies we observe enhanced differentiation.  This 
data suggests that PTBP1 may have separate roles in differentiation and splicing 
and may involve interactions with other factors.  Xist splicing isn't mediated by 
differentiation inhibition by PTBP1. Additionally differentiation induced Xist 
splicing isn't mediated by differentiation induced downregulation of PTBP1.  This 
further suggests that PTBP1's regulation of Xist may be indirect and require 
binding to other factors that promote splicing of the transcript.   
 Loss of spliced Xist has been associated with inefficient induction XCI. 
Impaired splicing of Xist observed in Ptbp1-/- ES cells would suggest impairment 
of silencing of X-linked genes.  However our data only saw modest increases in 
two of the XCI target genes studied (G6px, Lamp2).  One possibility is since 
Ptbp1-/- didn't completely inhibit splicing; that a small amount of spliced transcript 
is sufficient to silence XCI targeted genes.  Another possibility is that expression 
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of these X-linked genes is still relatively low at this point in differentiation, thus 
masking any changes in silencing since we do not see much a change in 
expression in WT ES cells between day 0 and day 8.  Another possibility is this 
assay may not be sensitive enough to accurately monitor silencing of X-linked 
genes.   
 How lncRNAs are transcriptionally being regulated is still a growing field. It 
is becoming increasingly apparent that RNA binding proteins are heavily involved 
in transcriptional regulation of lncRNAs and this is developmentally regulated 
however the mechanisms and interacting proteins are still being studied.  Xist is 
one of the most studied lncRNAs and its function in XCI is well understood, 
however the mechanisms that regulate its expression and function are still a 
mystery.  
 LncRNAs have less efficient splicing due to lower amount of functional 
splicing enhancers, lower binding to splicing regulator U2AF, lacking of 
cooperative splice sites for binding to SR proteins, and weak polypyrimidine 
tracts (Krchnakova et al., 2018). PTBP1 binds to the E-repeat of Xist in exon 7, 
downstream of intron 6. PTBP1 is more commonly known for repressing splicing 
of its target exons by blocking binding U2AF binding resulting in alternative exon 
exclusion, our results suggest the opposite for Xist (Sauliere et al., 2006).  One 
possibility is that PTBP1 binding to the E-repeat serves as a landing pad for SR 
proteins or other factors that promote splicing.  Alternatively PTBP1 expression 
controls additional splicing factors that interact with Xist.  Since PTBP1 regulation 
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appears to be indirect, future studies will need to be done to identify what binding 
partners bind to PTBP1 when it's bound to Xist in differentiated ES cells.   
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Materials and Methods 
Cell culture  
Feeder dependent female WT and Ptbp1-/- BL6 mouse ES cells were expanded 
on inactive male murine embryonic fibroblast (MEF) feeders on 0.1% gelatinized 
tissue culture plates in DMEM media (Gibco cat. no.10313039) supplemented 
with 15% ESC grade FBS (Gibco cat. no.10439024), 1% Nucleosides (EMD 
Millipore cat. no. ES008D), 1% Glutamax (Gibco cat. no.35050061), 0.1mM beta 
mercaptoethanol (Acros Organics cat. no. 125472500), and 1000 U/ml mLIF 
(EMD Millipore cat.no. ESG1106). To prevent emerging of colonies and 
spontaneous differentiation, media were changed every day and cells were 
passaged every two days on male feeders. Feeder independent female WT and 
Ptbp1-/- BL6 mouse ES cells, and WT female F1 2-1 mouse ES cells were 
expanded on 0.1% gelatinized tissue culture plates in 2i culture media containing 
50% Neurobasal (Gibco cat. no. 21103049) and 50% DMEM/F12 (Gibco cat. no. 
11320082) supplemented with 1% B27+RA (Gibco cat. no. 17504044), 1% N2 
Supplement (R&D System cat.no. AR009), 1% Glutamax, 7.4 mM B27 Fraction V 
(Gibco cat. no. 15260037), 1% Penicillin-Streptomycin (GE Healthcare Life 
Sciences cat. no. SV30010), 3 µM CHIR99021 (Sigma cat.no. SML1046), 1 µM 
PD0325901 (Selleckchem cat. no. S1036), 150 µM 1-thioglycerol (Sigma cat. no. 
M6145), and 1000 U/ml mLIF (Gemini Bio-Products cat. no. 400-495). To assist 
in initial attachment, 2i medium was supplemented with 2% ESC grade FBS for 
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the first 24 hours then switched to serum free. To prevent emerging of colonies 
and spontaneous differentiation, cells were passaged every two days.  
Differentiation of embryonic stem cells 
For monolayer differentiation, cells were plated at 200-300 x 103 per 6-well and 
were grown in LIF conditions for 24hrs and then LIF was removed and cells were 
grown in differentiation media for 24 hours (DMEM supplemented with 15% ESC 
FBS, 1% Nucleosides, 1% L-glutamine, 0.1mM beta mercaptoethanol, and 1 µM 
retinoic acid (Sigma cat. no. R2625). RNA was collected at 24 hours post retinoic 
acid addition. To generate embryoid bodies, feeder independent WT ES F1 2-1, 
WT C57B6, and Ptbp1-/- ES cells were plated at a density of 2.5 x 106 cells on 
0.5% Agarose coated polystyrene dishes (Grenier Bio-One cat. no. 633102) and 
maintained in DMEM supplemented with 10% FBS, 1% Glutamax, 1% Non-
Essential Amino Acids (GE Healthcare, cat. no. SH3023801), 1% Sodium 
Pyruvate (Lonza cat. no. 13-115E), and 0.1mM betamercaptoethanol without 
mLIF for up to 8 days. For western blots, WT and Ptbp1-/- mESCs were plated at 
300 x 103 on 0.5% agarose coated 6-well dishes (VWR, cat. no. 10062-892) to 
generate embryoid bodies. To minimize cell death, media was replenished every 
2 days.  
Actinomycin D Treatments 
Cells were plated at 100 x 103 per 6-well for 24 hours (h) prior to actinomycin D 
treatment. For stability experiments, cells were treated with 5 µg/ml actinomycin-
D (Sigma, cat. no. A1410) or an equal volume of DMSO vehicle (Sigma, cat. no. 
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D2438) in growth media for 8 h. RNA was collected at 0, 2, 4, 6, and 8 h post 
treatment. Expression of Xist was calculated using the ΔΔCT method before and 
after treatment. Percent Xist remaining was calculated as the ratio of Xist 
transcripts at the time of collection relative to time 0.  
Generation of Ptbp1-/- ES cells 
Mouse Ptbp1loxp/loxp ES cells were generated following a previously published 
protocol (10). In brief, healthy E3.5 blastocysts were collected from Ptbp1loxp/loxp 
intercrosses and individually cultured in KSOM medium (DMEM high glucose 
with 15% (vol/vol) KO serum, 2 mM GlutaMAX,1 mM sodium pyruvate, 0.1 mM 
MEM NEAA, 0.1 mM β-Mercaptoethanol, 103 U/ml of LIF, 1 µM PD0325901 and 
3 µM CHIR99021. After overnight culture, blastocysts were transferred to defined 
serum-free medium (1:1 mixture of DMEM-F12/N2 and Neurobasal/B27, 1 mM 
GlutaMAX, 0.5 mM sodium pyruvate, 0.1 mM MEM NEAA, 0.1 mM β-
Mercaptoethanol) plus 2i/LIF to allow attachment to the feeder layer. After 
outgrowth from blastocysts, cells were disaggregated and cultured in the serum-
free medium plus 2i/LIF together with MEF. Cells were monitored daily for colony 
formation. Cells exhibiting differentiation or atypical ES cell morphology were 
discarded and the healthy ES cell lines were maintained in the serum-free 
medium plus 2i/LIF with MEF. Ptbp1-/- mES cells were generated via expressing 
Cre recombinase in Ptbp1loxp/loxp ES cells. Ptbp1 homozygous knockout ES cell 
clones were identified by PCR genotyping and confirmed by PTBP1 Western 
blot. 
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RNA Isolation, cDNA synthesis, and RT-qPCR 
Trizol isolation of RNA was performed following manufacturer's protocol (Life 
Technologies). Isolated RNA was treated with 4 units of Turbo DNase (Ambion) 
at 37 °C for 35 minutes to degrade any remaining DNA. RNA was purified using 
Phenol-Chloroform (pH 4.5, VWR cat. no. 97064-744). RNA concentrations were 
measured using Nanodrop 2000c (Thermo Fisher). First-strand cDNA was 
generated using 1 µg RNA and 200 units of M-MLV reverse transcriptase 
(Promega cat. no. M1705) with a RT primer in a 20 µl reaction following the 
manufacturer's protocol. For Xist specific analysis, the RT primer was a Xist gene 
specific reverse primer (E6-E7 reverse) targeting exon 7 (50µM). For X-linked 
and differentiation genes random hexamers (30µM) were used. For 
polyadenylated (poly(A)+) RNA, oligodT primers (50µM) were used for cDNA 
generation. The RT-qPCRs were conducted using a Quantstudio 6 Flex Real-
Time PCR instrument, 2x Syber Master Mix (Life Technologies) following 
manufacturer's protocol. Three technical replicates of all samples were 
performed for each biological replicate. An additional no-template control was 
included in every experiment. Outliers were defined by a Ct variance higher than 
0.5. Analysis was done with Quanstudio 6 software and Microsoft Excel. 
Statistics test were based on ∆∆Ct values. 
Splicing assay 
RT-PCRs were performed under standard conditions for Taq polymerase from 
New England Biolabs (cat. no. M0267E). For amplification of spliced regions of 
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Xist spanning exons 1-2, exons 2-3, and exons 2-6, exon specific primers for 
corresponding exons were used (Supplemental Table 1). The PCRs were 
performed at a Tm of 60C for 29-35 cycles. PCR products greater than 1kb were 
resolved in 1.5% TAE Agarose gel. Smaller products were resolved with capillary 
electrophoresis (QIAxcel Advanced System) or on a 2% TBE Agarose gel. 
Relative quantities of spliced and unspliced products were measured on the 
QIAxcel software (Qiagen) or ImageLab (Bio-Rad) and the splicing ratio was 
calculated as the molar ratio of spliced to unspliced PCR products. The 
electropherograms of capillary electrophoresis were converted to virtual gel 
images by QIAxcel for presentation.  
Immunoblotting 
For primary antibodies, we used antibodies to PTBP1-NT (1:1,000), PTBP1-CT 
(1:200), PTBP2 (1:2,000), GAPDH (1:1,000, Ambion, AM4300). For secondary 
antibodies we used Alexa Fluor 488 donkey anti rabbit (Invirogen, A21206) 
and AF 647 donkey anti mouse (Invirogen, A31571).    
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Chapter 4: Allele specific silencing of the X-chromosome and X-
chromosome Inactivation. 
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Abstract 
During early development in female placental animals, one of the  
X-chromosomes are silenced through the epigenetic process of X-chromosome 
inactivation (XCI). Random XCI occurs post-implantation in the epiblast and 
includes the counting and choice of which X-chromosome to inactivate prior to 
increasing expression of Xist from the future inactivate chromosome.   The 
decision of which chromosome to inactivate is normally random.  However, XCI 
is skewed in hybrid mice as determined by the alleles of the X-controlling 
element (Xce) locus.  Cattanach over 40 years ago identified the Xce locus as 
the main determinant of XCI skewing however the mechanism is currently 
unknown (Cattanach and Isaacson, 1967).  The Xce locus is unknown, however 
identified candidate regions overlap with X-inactivation center that includes the 
Xist gene (Thorvaldsen et al., 2012; Chadwick et al., 2006; Simmler et al., 1993; 
Cattanach and Papworth, 1981). The four known Xce alleles are defined based 
in order of which Xce will remain active during XCI: Xcea < Xceb < Xcec < Xced 
(Rastan, 1982). Here we use F1 2-1 ES cells that are a Mus musculus 
129SvJaeJ (129) /Mus custaneous (CAS) heterozygote. The 129 allele has an 
Xcea  and the CAS allele has a Xcec with XCI skewed to inactivate the 129 allele.  
Prior to differentiation both Xist129 and XistCAS RNA are unspliced.  Differentiation 
of Xist129 exhibits higher splicing efficiency than XistCAS, contributing to it being 
preferentially silenced during XCI. Additionally, our single cell analysis shows that 
allelic choice of Xist splicing is linked to which X-chromosome is silenced. 
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Introduction 
Dosage compensation in females is accomplished by the epigenetic silencing of 
one of the X-chromosomes in females during early development.  Once 
established in the embryo, the inactivated X-chromosome is maintained 
throughout development.   
 In female placental animals, one of the X-chromosomes is silenced 
through the process of X-chromosome inactivation.  This occurs in two phases, 
imprinted and random XCI. Imprinted XCI is mediated by expression of Xist from 
paternal chromosome during the 2 to 8 cell stage of development. Cells that 
develop into the extraembryonic tissues and the trophoectoderm will maintain 
imprinted XCI.  The cells that will undergo differentiation and cell-lineage 
specification into the embryo undergo X-chromosome reactivation to remove the 
epigenetic marks on the paternal X-chromosome in the epiblast cells of the 
blastocyst.  Differentiation of the epiblast induces the second phase of silencing, 
called random X-chromosome Inactivation. During random XCI, either the 
paternal or the maternal X-chromosome will be silenced.  Random XCI is thought 
to be a multi-step process of first counting of the X-chromosomes, stochastic 
choice of which X-chromosome to inactivate, expression of Xist from inactive X-
chromosome, followed by initiation, spreading, and maintenance of the inactive 
state on the inactive X-chromosome.  
 Theoretically, silencing of the Xp or Xm in an individual should be found at 
equal ratios in cells, however this is not the case in cells derived from 
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heterogenic backgrounds.  In mice where both X-chromosomes are from 
homogenic backgrounds, the ratio of inactive Xp to Xm is closer to 50:50.  
However in heterozygous mice, skewing of XCI is observed (Calaway et al., 
2013).  Extent of skewing of XCI has been dependent on the alleles of the X 
controlling element (Xce) identified by Cattanach (Cattanach and Isaacson, 
1967).   To date four alleles of the Xce has been described based on how often a 
specific X-chromsome allele remains active.  Currently 4 main Xce alleles have 
been identified according to likelihood of remaining active: Xcea < Xceb < Xcec < 
Xced (Cattanach, 1991; Johnston and Cattanach, 1981; West and Chapman, 
1978; Cattanach and Williams, 1972; Cattanach, Pollard, and Perez, 1969; 
Cattanach and Isaacson, 1967).  Mus musculus 129 SvJaeJ (129) mice have a 
Xcee allele versus the Xcec allele found in Mus castaneous (CAS) and F1 2-1 ES 
cells have shown XCI skewing, with the X-chromosme derived from 129 mice 
being silenced ~70% of the time.  
 How the Xce functions in XCI skewing is not well understood however the 
locus candidate region has been identified as overlapping the Xic region that 
expresses Xist and Tsix, suggesting a potential regulation of the Xic by the Xce 
(Chadwick et al., 2006). Currently there are three favored models of X-
chromosome silencing 1) The blocking factor mode consisting of a blocking 
factor expressed on autosomes that can prevent XCI on the active X-
chromosome, 2) The two factor model in which autosomes express a  blocking 
factor that will competently bind to a trans-acting competent factor from the X-
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chromosome and the non bound factor will inactivate the X-chromosome 3) The 
sensing and choice model : after cells differentiate the Xpr region on the two X-
chromosomes pair and the Tsix/Xite regions determine which X-chromosome to 
silent (reviewed by Starmer and Magnuson, 2009).  The stochastic model 
suggested by Monkhorst and colleagues proposes that a trans-acting factor is 
produced from autosomes to activate Tsix and while an unknown X-linked gene 
produces a trans-acting factor that promotes Xist (Monkhorst et al., 2008). If the 
concentration of Xist expressed is sufficient, XCI will occur.  The stochastic 
model suggests that binding sites on each of the X-chromosomes will determine 
which X-chromosome will silence.  For example if one of the X-chromosome is 
more sensitive to the Xist promoting factor, it will preferentially be silenced.  
 Each of the current proposed models suggest that a trans-acting factor is 
involved in the choice of the X-chromosome to silence, however the mechanism 
of this regulation is still unknown.  To understand skewing and gain more insight 
on potential mechanisms of how the choice of which X-chromosome to silence is 
made, we focused our studies the hybrid F1 2-1 ES cells derived from a cross of 
Mus musculus 129SvJaeJ  and Mus musculus castaneous EiJ mouse strains.  
These cells are the favored models for studying XCI because the F1 2-1 ES cell 
line preferentially silences the X-chromosome derived from the 129 allele when 
differentiation is induced.   
 If trans-acting factors are required for inactivating the X-chromosome as 
the previous models suggest, there is still the remaining question of what 
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mechanism promotes the inactivation of one X-chromosome versus the other 
and how this relates to known existence of the Xce role in X-inactivation skewing.   
 In the previous two chapters I observed splicing as an important regulatory 
checkpoint for XCI induction.  Allele specific splicing has been observed in 
mRNA, considering Xist is processed very similar mechanism to mRNA splicing, 
splicing may be one of the factors that determine which X-chromosome is 
silenced based on which allele is more efficient at splicing of the Xist gene (Li et 
al., 2012). We found that both Xist129 and XistCAS are unspliced in female F1 2-1 
undifferentiated ES cells.  Upon differentiation Xist129 exhibits higher splicing 
efficiency than XistCAS, likely playing a role in the preferential inactivation of the 
X129 chromosome. Analysis of X-linked genes, we found that the choice of which 
X-chromosome to silence is linked to which X-chromosome is more efficiently 
spliced.  
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Results  
Allelic difference in Xist RNA splicing efficiency is associated with skewed 
Xist induction 
Differentiation induced X-inactivation is random in mice, however has been found 
to be skewed in certain female inbred lines.  Female mice carrying two X-
chromosomes from the same genetic background display random XCI.  However 
in mice heterozygous for the X-chromosomes from different genetic 
backgrounds, skewed XCI is observed.  Female hybrid mice will preferentially 
silence one X-chromosome over the other and it has been associated with the 
strength of the X chromosome controlling element allele (Calaway, 2013).  
Strains with weaker Xce, will be preferentially silenced in hybrid mice, however 
the mechanism is currently unknown.   
 For example, in the 129/Castaneous hybrid mice, the 129 line has been 
shown to carry the weakest allele Xcea compared to the stronger Xcec found in 
Castaneous mice.  This stochastic allelic difference at the X-chromosome is 
associated with the preferential expression of Xist from the X129 rather than from 
the XCAS.  The mechanism of skewed XCI is currently unclear, however it likely 
involves different events between the Xic and the Xce during the choice and 
initiation step of XCI.  Sequencing of all the exon-intron boundaries of Xist using 
genomic DNA from M. musculus 129SvJaeJ and M. musculus castaneus EiJ, I 
observed many deletions and SNPs. between the two alleles.  I observed in 
Chapter 2 and 3 that splicing appears to be an early regulator of Xist regulation.  
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We hypothesize that nonrandom Xist induction was associated with allelic 
differences in RNA splicing.  
 In order to measure both unspliced and spliced Xist variants derived from 
the 129 and CAS alleles, a polymorphic site located in an exon close to the 5' or 
3' splice site and compatible with a splicing assay is needed. We cloned and 
sequenced the exon-intron boundaries spanning the entire Xist genomic 
sequence using genomic DNA from M. musculus 129SvJaeJ and M. musculus 
castaneous wildtype mice.  We found a single nucleotide polymorphism (SNP) 
located in exon 3 close to the 3' splice site which generated a Tfi1 restriction 
enzyme recognition site only in the CAS allele (Figure 11A and B). 
 To validate the new SNP, we PCR amplified the sequences flanking the 
polymorphic site in both M. musculus 129SvJaeJ and M. musculus castaneus EiJ 
genomic DNA.  Primers that annealed to Exon 2 (E2-F2) and Exon 3 (E2E3-R) 
produced an uncut product of 281nt.  Primers that annealed to Intron 1 (I1E2-F) 
and Exon 3 (E2E3-R) yielded products that were 408 nt in length (Figure 11C).   
Amplified PCR products from the CAS allele were sensitive to Tfi1 restriction 
enzyme digest and were completely digested resulting in faster migrating bands 
(232 bp and 49 bp for the E2F2 amplicon and 359 bp and 49 bp for the I1E2-F 
amplicon).  The 129 allele was resistant to Tfi1 restriction digestion resulting in 
slower migrating uncut amplicons  (408 bp for E2F2 amplicon and 281 bp for 
I1E2-F amplicon).  These results validated the use of Tfi1 digestion of RT-PCR 
products to distinguish Xist129 and XistCAS RNA in our splicing assay. 
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 To examine the splicing efficiency of XistCAS AND Xist129 RNA, we 
preformed RT-PCR followed by restriction enzyme fragment length 
polymorphism (RFLP) analysis for to quantify each allele's expression based on 
the Tfi1 site. In undifferentiated F1 2-1 embryoid bodies, we observed primarily 
unpsliced forms of both the XistCAS  and Xist129 transcript, consistent with our 
previous data that Xist  is not efficiently spliced in undifferentiated cell conditions.   
Analysis of the E2F2 amplicon shows a steady decrease of the unspliced 
transcript originating from the Xist129 transcript that correlates with the steady 
increase of the spliced Xist129 transcript at day 4 and day 8.  We also observed 
similar results in the XistCAS transcript, however the majority of the spliced 
transcript originated from the Xist129 (Figure 11D). Although we see both XistCAS 
and Xist129 RNA display increased splicing efficiency, the Xist129 splicing ratio 
(spliced/unspliced) was significantly higher than that of XistCAS (Figure 11E). This 
data suggested more efficient splicing is associated with preferential expression 
of Xist129 RNA.  
 To further test the different splicing efficiencies between XistCAS and 
Xist129, we directly measured the premature unspliced Xist RNA.  I1E2-F and 
E2E3-R primers only amplified the premature unspliced Xist RNA. Similar to the 
results seen in with E2-F2 and E2E3-R primers, precursor Xist129 was 
consistently lower than XistCAS. Quantification of the Xist129 / XistCAS ratio before 
and after differentiation also showed that Xist129 precursor RNA was consistently 
lower than XistCAS precursor RNA.  Additionally the Xist129/XistCAS ratio decreased 
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with differentiation, showing that Xist129 is spliced more efficiently 
Allelic specific splicing of Xist  is linked to the choice of which X-
chromosome to silence 
To test whether allele specific splicing of Xist was related to the choice of which 
to which chromosome is silenced during X-inactivation, we compared allelic 
splicing of Xist to allelic expression of X-linked genes.  X-linked genes to use in 
the analysis had to follow two conditions 1) had an allelic specific restriction 
enzyme site and 2) was a target of X-chromosome inactivation.  Following these 
two conditions, we performed Restriction fragment length polymorphism analysis 
on XCI target genes G6pdx and Ogt.  Since XCI results in a population of cells 
that will either have the X129 or the XCAS silenced, we needed to isolate single 
cells that each had one X-chromosome silenced to determine the splicing 
patterns of each cell. We differentiated F1 2-1 hybrid cells and isolated single 
cells from embryoid bodies by fluorescent activated cell sorting (FACS). Using 
Smart-Seq, we isolated cDNA from single intact cells and performed restriction 
fragment length polymorphism analysis to determine allele specific X-linked gene 
expression (Figure 12A). 
 X-inactivation is suggested to be a sequential process (reviewed in Goto 
and Monk, 1998; Takagi et al., 1982; Monk and Harper, 1979).   
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Figure 11. Allelic difference in Xist splicing is associated with non-random 
Xist induction (A,B) Schematics of the primer locations and allele-specific 
restriction enzyme digestion for distinguishing the unspliced and spliced Xist 
transcripts from the Xist129 and XistCAS alleles. SNP induced Tfi1 cut site is 
present in exon 3 of the XistCAS allele. (C) A representative gel showingTfi1 
specifically cuts exon 3 of XistCAS/CAS genomic DNA but not Xist129/129 DNA.  
Genomic DNA was amplified using the I1E2F or the E2F2 forward primer and the 
E2E3R primer before Tfi1 treatment. (D) Splicing assay detects allele-specific 
expression of unspliced and spliced transcripts from the Xist129 and XistCAS alleles 
before and after differentiation. (E) Quantification of intron 2 splicing ratios of 
XistCAS and Xist129 transcripts, respectively. (F) A representative RT-PCR virtual 
gel image shows the expression of unspliced XistCAS and unspliced Xist129 
transcripts using I1E2-F and E2E3-R primers. (G) Ratios of unspliced Xist129 
transcript relative to unspliced XistCAS transcript upon differentiation. Error bars 
indicate S.E.M of 3 biological replicates 
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In female ES cells three patterns of Xist expression have been observed: 1) low 
level bi-allelic expression of Xist from both active X-chromosomes characteristic 
of undifferentiated ES cells, 2) differential bi-allelic expression of Xist that 
changes over time, and 3) mono-allelic expression of Xist from one X-
chromosome (Panning, Dausmann, and Jaenisch, 1997). In ES cells low levels 
of bi-allelic expression of Xist was characteristic of undifferentiated cells.  Cells 
induced to embryoid bodies lose this bi-allelic expression of Xist and begin to 
display differential bi-allelic expression of Xist, suggesting an intermediate phase 
in which the selected Xi begins to be more efficient at expressing Xist and 
silencing X-linked genes, how this is regulated is currently unknown. Cells don't 
begin to display mono-allelic expression of Xist until day 6 after Xist dependent 
XCI has already irreversible and XCI is fully established.  
 In our data we found some single cells expressed Xist from both X-
chromosomes (Figure 12B-D) and some did not (Figure 13A-B).  Some of the 
cells expressed unprocessed Xist from both X-chromosomes.  This appears to 
follow with the intermediate stage as described by Panning's group.  In those 
cells although both transcripts are expressed, only the Xist129 appears to be 
spliced. This data suggests that these cells likely fall into category two and fall 
into the intermediate stage of Xist inactivation.  The cells that only express Xist 
from one chromosome only express the Xist129, consistent with the skewing that 
has been previously seen in F1 2-1 ES cells.  These EBs were collected from 6- 
8 days and based on previous groups work likely represent the cells that have 
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enter the irreversible phase of XCI when cells have committed to inactivating one 
of the X-chromosomes (Wutz and Jaenish, 2000).  
 In F1 2-1 cells there is a strong skewing of XCI that preferentially silences 
the X129 allele.  In mature cells, assessing allelic choice cannot be fairly assessed 
because at this time point the XCI is established and the choice step of XCI has 
been made. In intermediate cells, bi-allelic transcription is still occurring and XCI 
is Xist dependent.  Using a time point when transcription and processing are still 
occurring will allow for more accurate analysis of splicing of each allele.  
 We found that all intermediate cells that predominantly spliced Xist129 also 
expressed X-linked genes from the XCAS chromosome (Figure 12B-D). In 12 out 
of 13 cells (all except #5) spliced XistCAS is not detectable, suggesting a strong 
selection for allelic specific splicing of Xist129.  Our RFLP analysis of these cells 
also showed strong expression of X-linked genes G6pdx and Ogt from the XCAS 
chromosome suggesting silencing of the same genes on the X129 allele (Figure 
12C-D).  Cell #5 had a very weak spliced XistCAS and appears to express a faint 
band for G6pdx and Ogt from both X129 and XCAS alleles. Cell #5 expressed 
significantly more Ogt from the XCAS allele consistent with XCI induction on the 
X129. It is likely that Cell #5 represents a cell that is early in the intermediate 
phase of XCI and is on its way to splice exclusively Xist129 and silence the X129 
exclusively.  
 The probability of observing 12-13 cells exclusively spliced Xist129 and 
inhibit the X129 is very small, and greater than what can be guessed by chance.  
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In all of the spliced cells the spliced Xist and the X-linked gene originated from 
opposing X-chromosomes (Figure 13A-B). Our observations suggest that allele-
specific splicing is intrinsically linked to the choice of the inactive X-chromosome.  
Additionally since the choice is made by the mature phase, our data suggests 
that splicing occurs during the intermediate phase or during the phase when XCI 
is both Xist dependent and reversible.  This is also consistent with our data that 
Xist splicing is required for Xist activity to induce XCI.   
 Based on data, I propose that during the undifferentiated phase, Xist is 
expressed from both alleles, however it is lowly expressed.  As differentiation is 
induced and cells enter the "intermediate" phase and still expressed Xist from 
both alleles, Xist more efficiently spliced on the X129.  As the intermediate phase 
proceeds, transcription is increased from the X129 chromosome as is splicing due 
to more efficient binding to the splicing machinery potentially assisted by the 
presence of PTBP1.  Spliced Xist is needed to recruit the repressive machinery 
to the X-chromosome.  While this is happening on the X129 chromosome, 
transcription and silencing is inhibited on the XCAS chromosome due to inefficient 
levels of spliced Xist to silence the XCAS, during the critical window of Xist 
dependent XCI resulting in silencing of the X129. 
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Figure 12. Allele specific Xist splicing is linked to the choice of inactive X 
chromosome (A,B) Schematics of the primer locations and allele-specific 
restriction enzyme digestion for distinguishing the unspliced and spliced Xist 
transcripts from the Xist129 and XistCAS alleles. SNP induced Tfi1 cut site is 
present in exon 3 of the XistCAS allele. (C) A representative gel showingTfi1 
specifically cuts exon 3 of XistCAS/CAS genomic DNA but not Xist129/129 DNA.  
Genomic DNA was amplified using the I1E2F or the E2F2 forward primer and the 
E2E3R primer before Tfi1 treatment. (D) Splicing assay detects allele-specific 
expression of unspliced and spliced transcripts from the Xist129 and XistCAS alleles 
before and after differentiation. (E) Quantification of intron 2 splicing ratios of 
XistCAS and Xist129 transcripts, respectively. (F) A representative RT-PCR virtual 
gel image shows the expression of unspliced XistCAS and unspliced Xist129 
transcripts using I1E2-F and E2E3-R primers. (G) Ratios of unspliced Xist129 
transcript relative to unspliced XistCAS transcript upon differentiation. Error bars 
indicate S.E.M of 3 biological replicates. ns, p-value>0.05; *, p-value < 0.05; **, 
p-value< 0.01; ***, p-value < 0.001. 
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Figure 13. Spliced Xist and X-linked genes originate from different X   
chromosomes in mature embryoid bodies A) Restriction fragment length 
polymorphism analysis combined with splicing assay detects allelic specific 
expression of unspliced and spliced Xist transcripts from the X129 and XCAS 
chromosomes in mature cells. F1 2-1 cells were differentiated using the embryoid 
body method for 8 days (with added retinoic acid from day 4). (B) Restriction 
fragment length polymorphism analysis detects allelic expression of X-linked 
genes Ogt from the X129 and XCAS chromosomes. G6pdx expression was not 
detectable in these samples.  
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Discussion 
In Chapter 2 we showed that differentiation induces post-transcriptional splicing 
of Xist during the early phases of XCI induction and in Chapter 3 we showed that 
PTBP1 is one of the RBPs involved in this process. In this chapter we found that 
during skewed XCI, Xist129 is preferentially spliced during the intermediate phase 
of XCI and found only Xist129 is fully spliced when XCI is established.  Xist is 
expressed from both X-chromosomes, however differentiation induced splicing is 
more efficient on the Xist transcript derived from the future inactive X-
chromosome suggesting splicing is a crucial regulatory step in deciding which X-
chromosome to silence. This data suggests that Xist expressed from the future Xi 
may be more efficient at recruiting transacting factors involved in splicing of the 
Xist transcript and the silencing of Xist activators on the active X-chromosome. 
This results is more spliced Xist being produced by future inactive X and its 
eventual silencing.  The data suggests that splicing efficiency may be a crucial 
mechanism involved in regulating Xist dependent X-chromosome inactivation.   
 In this chapter, we have examined whether splicing played a role in allelic 
choice of which X-chromosome to silence during induction of X-chromosome 
inactivation. Using a combination of RT-PCR from individual ES cells and 
restriction fragment length polymorphism analysis (RFLP), our studies in hybrid 
X129/XCAS ES cells showed a link between differentiation induced splicing and 
skewed XCI.   In our hybrid F1 2-1 cells Xist129 and XistCAS  were differentially 
spliced suggesting an existence to splicing factors or elements that appear to be 
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sensitive to differentiation conditions since both remain primarily unspliced in 
undifferentiated ES cells.  Based on our results in Chapter 3, these splicing 
factors may interact with PTBP1 since loss of PTBP1 resulted in significant 
reduction of splicing.   
  XCI skewing has been attributed to the preferential silencing of the X-
chromosome that has the weakest X controlling element however the mechanism 
of this regulation is still a mystery (Cattanach, 1991; Johnston and Cattanach, 
1981; West and Chapman, 1978; Cattanach and Williams, 1972; Cattanach, 
Pollard, and Perez, 1969; Cattanach and Isaacson, 1967). There is an intrinsic 
bias to express Xist from the X129 during XCI induction due the presence of the 
Xcea allele, which is the weakest of the 4 identified X controlling element alleles.   
 Although it has been proven in other studies that hybrid F1 2-1 ES cells 
skew inactivation in favor of silencing the X129, the mechanism of this silencing 
hasn't been studied in depth.  Our data is the first to show differential splicing 
between the Xist129 and XistCAS as one of the potential mechanisms of the choice 
of which X-chromosome to silence.  Some studies have suggested that structural 
variances within segmented duplications present in the candidate Xce locus may 
be the cause of these variances in Xce allele strength due to potential differences 
in binding sites for transacting factors (Calaway et al., 2013;, Yalcin et al., 2011). 
Our work expands upon previous work and suggests that these transacting 
factors may be involved in splicing and that Xist129 may be more efficient in 
recruiting such factors during the intermediate phase of XCI.   
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 One caveat to this data however is that during single cell collection we 
were not able to isolate cells that expressed XistCAS. Previous studies showed 
that XCI preferentially silences the X129 about 75% of the time in hybrid X129/XCAS 
cells, however in our bulk cell analysis the ratio of splice Xist129/ XistCAS was 
closer to10:1 (Calaway, 2013).  Therefore in our cells, capturing the XistCAS is 
difficult prior to any additional selection steps.  We used three stringent gates to 
isolate viable single cells using FACS, resulting in only about 1% being selected 
(refer to methods).  If inactivating XCAS had any changes on the morphology, 
viability, or size of the cells, these may have been selected against during FACS. 
Embryoid bodies are made from suspension cultures resulting in a 
heterogeneous population of cell aggregates of different shapes and sizes, which 
may influence differentiation of individual cells. Differentiation of ES cells is 
largely directed by the microenvironment that the cells are exposed to, and the 
cells position in embryoid bodies plays a role in the differentiation status and cell 
fate of those cells (Karp et al., 2011; Hamazaki et al., 2004). Our cells were 
isolated from embryoid bodies, therefore this variance in allelic splicing status we 
see in our data may be partly due to this inherent variance found in ES cells 
isolated from EBs.  For example, the cells that appear to be in the intermediate 
phase of XCI induction may have been less differentiated or in an earlier cell 
state when differentiation was induced than cells that have completed splicing of 
Xist by the time of our cell collection.  
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 Splicing of lncRNAs are intrinsically less efficient than protein coding 
genes, splicing is highly dependent on 5' splice site strength and thymidine rich 
polypyrimidine tracts due to lncRNA's inability to efficiently recruit the splicing 
machinery (Krchňáková et al., 2018).  SR protein binding to lncRNAs is less 
efficient than in protein coding genes. It is possible that the Xcea has more 
binding sites for trans acting SR Proteins and those proteins interact more 
efficiently with certain factors that can bind to Xist129 more efficiently than XistCAS.  
 Deletion of the A-repeat on Xist129 in exon 1 of Xist results in depletion of 
spliced Xist and failure to induce XCI on the X129. Depletion of ASF/SF2, which 
binds to the A-repeat, also results in failure to spliced Xist. Mutant cells lacking 
the A-repeat expressed similar levels of the primary transcript to the WT. These 
results are consistent with spliced Xist being needed for functional XCI (Royce 
Tolland et al., 2010). 
 In both the Royce-Tolland study and ours, Xist is either completely spliced 
or completely unspliced. Binding of RBPs involved in splicing regularly effects the 
splicing of the exon it is bound to. However both the Royce-Tolland study and our 
study show that loss of splicing effects all of exons.  Our data is consistent with 
the notion that Xist splicing might be essential for Xist to form the high order 
structures required for interactions with the X-chromosome.  This would be 
consistent with the need for Xist to be completely spliced.  
 The observation that both unspliced Xist129 and XistCAS are expressed in 
the intermediate phase, however only spliced Xist129 is observed in the mature 
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phase suggests that splicing of Xist on the Xi results in inhibition of Xist 
expression on the Xa. These data is consistent with splicing efficiency 
contributing to allelic choice of which X-chromosome to silence during induction 
of XCI.  Determining the source of splicing repression on the Xa and activation 
on the Xi and the binding partners involved could reveal novel splicing regulatory 
mechanisms of Xist.    
 Both the importance and mechanisms of long noncoding RNA splicing is 
still a mystery but appears to be primary sequence dependent to interact with 
RBPs. The work in this chapter suggest a role of splicing for the lncRNA Xist, 
however may provide insight in the importance of splicing of lncRNAs to their 
function and specificity that may be applied to the studies of other lncRNAs.  
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Materials and Methods 
Differentiation of embryonic stem cells 
To generate embryoid bodies, feeder independent WT ES F1 2-1, WT C57B6, 
and Ptbp1-/- ES cells were plated at a density of 2.5 x 106 cells on 0.5% Agarose 
coated polystyrene dishes (Grenier Bio-One cat. no. 633102) and maintained in 
DMEM supplemented with 10% FBS, 1% Glutamax, 1% Non-Essential Amino 
Acids (GE Healthcare, cat. no. SH3023801), 1% Sodium Pyruvate (Lonza cat. 
no. 13-115E), and 0.1mM betamercaptoethanol without mLIF for up to 8 days. To 
promote embryoid body differentiation, 2 µM retinoic acid was added to the 
media of embryoid bodies on days 4 thru 8 and replenished every two days. For 
western blots,. To minimize cell death, media was replenished every 2 days 
RNA Isolation, cDNA synthesis, and RT-qPCR 
Trizol isolation of RNA was performed following manufacturer's protocol (Life 
Technologies). Isolated RNA was treated with 4 units of Turbo DNase (Ambion) 
at 37 °C for 35 minutes to degrade any remaining DNA. RNA was purified using 
Phenol-Chloroform (pH 4.5, VWR cat. no. 97064-744). RNA concentrations were 
measured using Nanodrop 2000c (Thermo Fisher). First-strand cDNA was 
generated using 1 µg RNA and 200 units of M-MLV reverse transcriptase 
(Promega cat. no. M1705) with a RT primer in a 20 µl reaction following the 
manufacturer's protocol. For Xist specific analysis, the RT primer was a Xist gene 
specific reverse primer (E6-E7 reverse) targeting exon 7 (50µM). For X-linked 
and differentiation genes random hexamers (30µM) were used. For 
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polyadenylated (poly(A)+) RNA, oligodT primers (50µM) were used for cDNA 
generation. The RT-qPCRs were conducted using a Quantstudio 6 Flex Real-
Time PCR instrument, 2x Syber Master Mix (Life Technologies) following 
manufacturer's protocol. Three technical replicates of all samples were 
performed for each biological replicate. An additional no-template control was 
included in every experiment. Outliers were defined by a Ct variance higher than 
0.5. Analysis was done with Quanstudio 6 software and Microsoft Excel. 
Statistics test were based on ∆∆Ct values. 
Allele specific splicing assay and restriction fragment length 
polymorphism analysis 
PCR reactions were performed under standard conditions for Taq polymerase 
(New England Biolabs) on RT products derived from WT F1 2-1 XCASX129 ES 
cells. For Xist 30-35 cycles was used.  For X-linked genes G6pdx and Ogt, 35-40 
cycles were used. PCR products were digested with 2.5 units of Tfi1 (New 
England Biolabs cat. no. R0546L) that specifically cut exon 3 on the XistCAS allele 
in a 25 µl reaction for 2 hours at 65°C.  For single cell studies, PCR products 
were digested with 2.0 units of restriction enzymes overnight at 37°C.  For 
analysis of X-linked genes, PCR products were digested with Ava1 (NEB, cat. 
no. R0152S) or ScrF1 (NEB, cat. no. R0110S) to cut Ogt or G6pdx respectively 
(Lin et. al. 2007, Minkovsky and Plath 2013, 18076287). To remove restriction 
enzymes, samples were purified using Agencourt AMPure XP magnetic beads 
(Beckman Coulter cat. no. A63881) following the manufacturer’s protocol. Eluted 
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PCR products were diluted 1:3 -1:5 when necessary before analysis on the 
Qiagen QIAxcel Capillary Electrophoresis system (Qiagen) using the QIAxcel 
DNA Screening Kit (Qiagen, cat. no. 929004) following the manufacturer's 
protocol. The QIAxcel Alignment Marker QX 15-600bp (Qiagen, cat. no. 929530) 
and the Qiaxcel 25-500bp size marker (Qiagen, cat. no. 929560) were used in 
the analysis. Allelic ratios were calculated as a ratio of X129 and XCAS allele 
specific Xist as determined by digestion with Tfi1. Splicing ratios were calculated 
as the ratio of spliced and unspliced Xist129 and XistCAS specific PCR products. 
For confirmation of allele specific digestion by Tfi1, genomic DNA collected from 
the brain of wildtype mus musculus castaneus EIJ and mus musculus 
domesticus 129S4/SvJaeJ mice (The Jackson Laboratory) were used.  
Single Cell Sorting and cDNA preparation 
WT F1 2-1 ES cells were differentiated into embryoid bodies for 6 days. Cells 
were washed two times with 1x PBS and stained with propidium iodide (PI) 
(1:1500) (BD Pharmigen, cat. no. 556547) to identify apoptotic cells.  We used 
three stringent gating steps to select single cells: (1) negative staining of 
propidium iodide as an indicator of healthy cells; (2) typical FSC and SSC 
settings to filter out cell debris and cell chunks; (3) linearity between SSC height 
and SSC area to ensure single cell (singlet in sorting). Single PI-negative WT F1 
2-1 cells from embryoid bodies were then sorted into PCR strips using a MoFlo 
Astrios EQ (Beckman Coulter) according to manufacturers' protocol.  Prior to cell 
sorting, quality calibrations (QC) were performed according to manufacturer’s 
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recommendation. The cDNA was prepared using SMART-Seq v4 Ultra Low Input 
Kit for 12 reactions (Clontech) according to manufacturer’s protocol.  
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Introduction 
LncRNAs have shown to be very important in regulation of gene expression; they 
are regulated in every tissue and at specific times.  The stringent regulation of 
lncRNAs suggests an evolutionary conserved mechanism to regulate gene 
expression.  For how important lncRNAs appear to be, very little is known on how 
they are transcribed and processed.  Many long noncoding RNAs appear to be 
spliced and processed in order to be functional, however very little is known 
regarding how splicing occurs.  Advances in genomic technologies have provided 
more insight in how these RNA transcripts work but have also led to additional 
questions. Xist's role in X-chromosome inactivation is one of the most understood 
functions of an lncRNA, however very little is known how Xist itself is regulated.  
The past few years have been focused on understanding each of the steps of 
XCI function, Xist transcriptional control, Xist spreading and localization, and 
repression. Recent works by many groups have identified known RNA binding 
proteins that interact with Xist (Vuong et al., 2016; Chu et al., 2015; Mchugh et 
al., 2015). Some of the proteins shed light on how Xist interacts with the X-
chromosome, however some suggest roles in Xist transcript regulation.  The 
identification of splicing factors PTBP1 and ASF2 to the E-repeat and the A-
repeat respectively suggested splicing might be a method of transcriptional 
regulation of Xist during XCI, a field that hasn't been studied in depth.   
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Conclusions and Future Directions 
In this thesis, we investigated how Xist is transcriptionally regulated during 
differentiation. The results from these studies reveal that while splicing is not the 
only regulation involved in Xist mediated XCI, splicing acts as a fail-safe 
mechanism to ensure that XCI is only induced on the future inactivate X-
chromosome. Prior to differentiation, Xist is lowly expressed and unspliced, and 
therefore XCI is not induced and both X-chromosomes remain active.  Upon 
differentiation and downregulation of pluripotency factors, Xist expression is 
upregulated.  However once Xist is expressed, it must determine which X-
chromosome to silence.  Our data suggests, that one of the X-chromosomes is 
more efficient at splicing of Xist and the accumulation of spliced Xist on the Xi 
may inhibit further expression of Xist from the active X-chromosome leading to 
this choice.  The need of trans-acting factors to splice lncRNAs has been 
suggested by other groups.  Our data suggests that PTBP1 may be one of the 
trans-acting factors involved in splicing of Xist .  However since PTBP1 has only 
been identified to bind to the E-repeat, a question as to how the other introns are 
spliced as the same time remains.  It is possible that PTBP1 serves as a 
scaffolding protein required to bring other splicing factors to the Xist. This 
mechanism of action suggests that splicing of Xist could be mediated by how Xist 
efficiently binds to these factors.  The 129 and CAS alleles of Xist are very 
different in their sequence and have the greatest skewing during XCI.  It is 
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possible that Xist129 can more efficiently bind to PTBP1 or additional factors and 
therefore be spliced more efficiently.   
 Therefore my data proposes the following model where Xist is lowly 
expressed by both X-chromosomes, upon differentiation Xist recruits additional 
factors to mediate it's splicing.  Once Xist levels reach a certain critical 
concentration, they recruit PTBP1 and additional factors.  Xist129 is more efficient 
at binding to PTBP1 and other transacting factors involved in it's splicing and 
therefore is spliced more.  As the spliced population of Xist from the X129 
increases, Xist splicing and transcription is silenced on the future active X-
chromosome.  
 Future studies will need to identify what binding partners to PTBP1 exist 
during XCI and if they also have binding sites with Xist. Once these binding 
partners are identified then experiments will need to focus on seeing if different 
X-chromosome alleles have differential binding.  Although our data doesn't 
answer all questions it does provide insight into a not well-studied field.  
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